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This Special Issue of the Annals of Actuarial Science contains 12 contributions to the academic 
literature all dealing with longevity risk and capital markets. Draft versions of the papers were 
presented at Longevity 14: The Fourteenth International Longevity Risk and Capital Markets 
Solutions Conference that was held in Amsterdam on 20-21 September 2018. It was hosted by 
the Pensions Institute at Cass Business School and the Netspar Network for Studies on 
Pensions, Ageing and Retirement. 
 
Longevity risk and related capital market solutions have grown increasingly important in recent 
years, both in academic research and in the markets we refer to as the Life Market, i.e., the 
capital market that trades longevity-linked assets and liabilities. 1 Mortality improvements 
around the world are putting more and more pressure on governments, pension funds, life 
insurance companies, as well as individuals, to deal with the longevity risk they face. At the 
same time, capital markets can, in principle, provide vehicles to hedge longevity risk 
effectively and transfer the risk from those unwilling or unable to manage it to those willing to 
invest in this risk in exchange for appropriate risk-adjusted returns or to those who have a 
counterpoising risk that longevity risk can hedge, e.g., life offices and reinsurers with mortality 
risk on their books. Many new investment products have been created both by the 
insurance/reinsurance industry and by the capital markets. Mortality catastrophe bonds are an 
early example of a successful insurance-linked security. Some new innovative capital market 
solutions for transferring longevity risk include longevity (or survivor) bonds, longevity (or 
survivor) swaps and mortality (or q-) forward contracts. The aim of the International Longevity 
Risk and Capital Markets Solutions Conferences is to bring together academics and 
practitioners from all over the world to discuss and analyze these exciting new developments.  
 
The conferences have closely followed the developments in the market. The first conference 
(L1) was held at Cass Business School in London in February 2005. This conference was 
prompted by the announcement of the Swiss Re mortality catastrophe bond in December 2003 
and the European Investment Bank/BNP Paribas/PartnerRe longevity bond in November 2004.  
 
The second conference (L2) was held in April 2006 in Chicago and hosted by the Katie School 
at Illinois State University.2 Since L1, there have been further issues of mortality catastrophe 
bonds, as well as the release of the Credit Suisse Longevity Index. In the UK, new life 
                                                 
+ David Blake [D.Blake@city.ac.uk] is Professor of Pension Economics and Director of the Pensions Institute, 
Cass Business School, City University of London, UK. Andrew J. G. Cairns [A.J.G.Cairns@hw.ac.uk] is 
Professor of Financial Mathematics at Heriot-Watt University, Edinburgh. David Blake and Richard MacMinn 
are co-founders of the Longevity Risk and Capital Markets Solutions Conferences. We are extremely grateful to 
Joost van Dun, Marilyn Parris-Bell and their colleagues for their superb organization of the conference. 
1 Blake et al. (2013). 
2 The conference proceedings for L2 were published in the December 2006 issue of the Journal of Risk and 
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companies backed by global investment banks and private equity firms were setting up for the 
express purpose of buying out the defined benefit (DB) pension liabilities of UK corporations.3 
Goldman Sachs announced it was setting up such a buy-out company itself (Rothesay Life) 
because the issue of pension liabilities was beginning to impede its mergers and acquisitions 
activities. It decided that the best way of dealing with pension liabilities was to remove them 
altogether from the balance sheets of takeover targets. So there was firm evidence that a new 
global market in longevity risk transference had been established. However, as with many other 
economic activities, not all progress follows a smooth path. The EIB/BNP/PartnerRe longevity 
bond did not attract sufficient investor interest and was withdrawn in late 2005. A great deal, 
however, was learned from this failed issue about the conditions and requirements needed to 
launch a successful capital market instrument.  
 
The third conference (L3) was held in Taipei, Taiwan on 20-21 July 2007. It was hosted by 
National Chengchi University.4  It was decided to hold L3 in the Far East, not only to reflect 
the growing importance of Asia in the global economy, but also to recognize the fact that 
population ageing and longevity risk are problems that affect all parts of the world and that 
what we need is a global approach to solving these problems.5 Since the Chicago conference, 
there had been a number of new developments, including: the release of the LifeMetrics Indices 
covering England & Wales, the US, Holland and Germany in March 2007 by J.P. Morgan, the 
Pensions Institute and Towers Watson;6 the world's first publicly announced longevity swap 
between Swiss Re and the UK life office Friends Provident in April 2007 (although this was 
structured as an insurance or indemnification contract rather than a capital market transaction). 
 
Since the Taiwan conference, there were further developments in the capital markets. In 
December 2007, Goldman Sachs launched a monthly index suitable for trading life 
settlements.7 The index, QxX.LS, was based on a pool of 46,290 anonymized US lives over 
the age of 65 from a database of life policy sellers assessed by the medical underwriter AVS. 
In 2008, Institutional Life Services (ILS) and Institutional Life Administration (ILA), a life 
settlements trading platform and clearing house, were launched by Goldman Sachs, Genworth 
Financial, and National Financial Partners. ILS and ILA were designed to modernize dealing 
in life settlements and meet the needs of consumers by ensuring permanent anonymity of the 
insured and of the capital markets by providing a central clearing house for onward distribution 
of life settlement assets, whether individually or in structured form.8 
 
Xpect Age and Cohort Indices were launched in March 2008 by Deutsche Börse. These indices 
cover, respectively, life expectancy at different ages and survival rates for given cohorts of 
lives in Germany and its regions, Holland and England & Wales.  
                                                 
3 With a buy-out, an insurance company buys out the liabilities of a pension scheme which is paid for with the 
pension scheme assets and a loan if the scheme is in deficit at the time. Both the pension scheme assets and 
liabilities are removed from the corporate sponsor’s balance sheet. Each member has a personal annuity from 
the insurer who takes over responsibility for paying the pensions. This contrasts with a buy-in, where the 
liabilities remain on the sponsor’s balance sheet, but the scheme buys a bulk purchase annuity (BPA) from an 
insurance company and pays members’ pensions from the annuity payments it receives from the insurer. The 
BPA is an asset of the scheme, not the members. 
4  The conference proceedings for L3 were published in the Fall 2008 issue of the Asia-Pacific Journal of Risk 
and Insurance. 
5  In fact, Asia has the world’s largest and fastest growing ageing population (United Nations, 2007). 
6 www.lifemetrics.com 
7  Life settlements are traded life policies. In April 2007, the Institutional Life Markets Association started in 
New York, as the dedicated institutional trade body for the life settlements industry. 
8  In 2010, National Financial Partners became the sole owner of ILS/ILA. 
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The world’s first capital market derivative transaction, a q-forward contract9 between J. P. 
Morgan and the UK pension fund buy-out company Lucida, took place in January 2008. The 
world’s first capital market longevity swap was executed in July 2008. Canada Life hedged 
£500m of its UK-based annuity book (purchased from the defunct UK life insurer Equitable 
Life). This was a 40-year swap customized to the insurer’s longevity exposure to 125,000 
annuitants. The longevity risk was fully transferred to investors, which included hedge funds 
and insurance-linked securities (ILS) funds. J. P. Morgan acted as the intermediary and 
assumed counter-party credit risk. In August 2011, ITV, the UK’s largest commercial TV 
producer, completed a £1.7bn bespoke longevity swap with Credit Suisse for its £2.2bn pension 
plan: the cost of the swap is reported as £50m (3% of the swap value). The largest to date, 
covering £16bn of pension liabilities, was the longevity swap for the British Telecom Pension 
Scheme, arranged by the Prudential Insurance Co of America (PICA) 10 in July 2014. In 
February 2010, Mercer launched a pension buy-out index for the UK to track the cost charged 
by insurance companies to buy out corporate pension liabilities: at the time of launch, the cost 
was some 44% higher than the accounting value of the liabilities which highlighted the 
attraction of using cheaper alternatives, such as longevity swaps. 
 
The fourth conference (L4) was held in Amsterdam on 25-26 September 2008. It was hosted 
by Netspar and the Pensions Institute.11 In 2008, Credit Suisse initiated a longevity swap with 
Centurion Fund Managers, whereby Centurion acquired a portfolio of synthetic (i.e., simulated) 
life policies, based on a longevity index built by Credit Suisse. In 2009, survivor swaps began 
to be offered to the market based on Deutsche Börse’s Xpect Cohort Indices.  
 
The fifth conference (L5) was held in New York on 25-26 September 2009.12 On 1 February 
2010, the Life and Longevity Markets Association (LLMA)13 was established in London. Its 
current members are Aviva, AXA, Deutsche Bank, J.P. Morgan, Morgan Stanley, Prudential 
(UK) PLC, and Swiss Re. LLMA was formed to promote the development of a liquid market 
in longevity- and mortality-related risks. This market is related to the ILS market and is also 
similar to other markets with trend risks, e.g., the market in inflation-linked securities and 
derivatives. LLMA aims to support the development of consistent standards, methodologies 
and benchmarks to help build a liquid trading market needed to support the future demand for 
longevity protection by insurers and pension funds. In April 2011, the LifeMetrics indices were 
transferred to LLMA with the aim of establishing a global benchmark for trading longevity and 
mortality risk. 
 
The sixth conference (L6) was held in Sydney on 9-10 September 2010.14 In December 2010, 
building on its successful mortality catastrophe bonds and taking into account the lessons 
learned from the EIB bond, Swiss Re launched a series of eight-year longevity-based ILS notes 
valued at $50m. To do this, it used a special purpose vehicle, Kortis Capital, based in the 
Cayman Islands. As with the mortality bonds, the longevity notes are designed to hedge Swiss 
                                                 
9  Coughlan et al. (2007). 
10 We will use PICA to refer to the US-based insurer, which is a Prudential Financial Inc. company, as well as 
Prudential Retirement and Prudential Retirement Insurance and Annuity Company (PRIAC).   
11  The conference proceedings for L4 were published in the February 2010 issue of Insurance: Mathematics and 
Economics. 
12  The conference proceedings for L5 were published in the North American Actuarial Journal (Volume 15, 
Number 2, 2011). 
13 www.llma.org 
14  The conference proceedings for L6 were published in the October 2011 issue of Geneva Papers on Risk and 
Insurance - Issues and Practice. 
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Re's own exposure to mortality and longevity risk. In particular, holders of the notes are 
exposed to an increase in the spread between mortality improvements in 75-85-year-old 
English & Welsh males and 55-65-year-old US males, indicating that Swiss Re has life 
insurance (mortality risk) exposure in the US and pension (longevity risk) exposure in the UK. 
 
In January 2011, the Irish government announced that it would issue bonds that allow the 
creation of sovereign annuities. 15  This followed a request from the Irish Association of 
Pension Funds and the Society of Actuaries in Ireland. If the bonds are purchased by Irish 
pension funds, this will have a beneficial effect on the way in which the Irish funding standard 
values pension liabilities. On account of a statutory deadline to submit a deficit repair plan, 
2013 was a record year for bulk annuity transactions in Ireland with sovereign annuities being 
used in a significant number of transactions. 
 
The world’s first longevity swap for non-pensioners (i.e., for active and deferred members of 
a pension plan) took place in January 2011, when J. P. Morgan executed a £70m 10-year q-
forward contract with the Pall (UK) pension fund. This was a value swap designed to hedge 
the longevity risk in the value of Pall’s pension liabilities, rather than the longevity risk in its 
pension payments as in the case of cash flow swaps which have been the majority of the swaps 
that have so far taken place. Longevity risk prior to retirement is all valuation risk: there is no 
cash flow risk and most of the risk lies in the forecasts of mortality improvements. Further, the 
longevity exposure of deferreds is not well defined as a result of the options that plan members 
have, e.g., lump sum commutation options, early retirement options, and the options to increase 
spouses’ benefits at the expense of members’ benefits.  
 
In April 2011, the International Society of Life Settlement Professionals (ISLSP)16 formed a 
life settlement and derivatives committee and announced that it was developing a life 
settlement index. The purpose of the index is to benchmark net asset values in life settlements 
trading. Investors need a reliable benchmark to measure performance and the index will help 
turn US life insurance policies into a tradable asset class according to ISLSP. The calculation 
agent for the index is AA Partners. 
 
The first pension risk transfers deals outside the UK took place in 2009-11. The first buy-in 
deal (i.e., bulk annuity purchase to hedge the longevity risk of pensions in payment) outside 
the UK took place in 2009 in Canada; it was arranged by Sun Life Financial and valued at 
C$50m. The first buy-in deal in Europe took place in December 2010 between the Dutch food 
manufacturer Hero and the Dutch insurer Aegon (€44m). The first buy-in deal in the US took 
place in May 2011 between Hickory Springs Manufacturing Company and PICA ($75m). The 
first buy-out deal outside the UK was announced in May 2011 and involved the C$2.5bn Nortel 
pension plan in Canada. In September 2011, CAMRADATA Analytical Services launched a 
new pension risk transfer (PRT) database for US pension plans. The database provides 
insurance company organisational information, pension buy-in and buy-out product fact sheets 
and screening tools, pricing data, up-to-date information on each PRT provider's financial 
strength and relevant industry research. Users can request pension buy-in and buy-out quotes 
                                                 
15 A sovereign annuity, introduced by the 2011 Social Welfare and Pensions Act, is an annuity contract issued 
by insurance companies where the annual income payment is linked directly to payments under bonds issued by 
Ireland or any other EU member state (known as reference bonds).  The payments can be reduced if there is an 
event of non-performance in relation to the bonds to which the annuity is referenced. This contrasts with a 
standard annuity where the insurer guarantees to make the agreed payments for the lifetime of the annuitant. 
16 www.islsp.org 
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directly from providers, including American General Life Companies, MetLife, Pacific Life, 
Principal Financial Group, PICA, Transamerica and United of Omaha. 
 
The first international longevity reinsurance transaction took place in June 2011 between 
Rothesay Life (UK) and PICA and was valued at £100m. The first life book reinsurance swap 
since the Global Financial Crisis took place in June 2011 between Atlanticlux and institutional 
investors and was valued at €60m. 
 
The seventh conference (L7) was held at the House of Finance, Goethe University, Frankfurt, 
Germany on 8-9 September 2011.17  
 
In February 2012, Deutsche Bank executed a massive €12 billion index-based longevity 
solution for Aegon in the Netherlands.  This solution was based on Dutch population data and 
enabled Aegon to hedge the liabilities associated with a portion of its annuity book. Because 
the swap is out of the money, the amount of longevity risk actually transferred is far less than 
that suggested by the €12 billion notional amount. Nonetheless, the key driver for this 
transaction from Aegon’s point of view was the reduction in economic capital it achieved. Most 
of the longevity risk has been passed to investors in the form of private bonds and swaps.   
 
In June 2012, General Motors Co. (GM) announced a huge deal to transfer up to $26 billion of 
pension obligations to PICA. This is by far the largest ever longevity risk transfer deal globally. 
The transaction is effectively a partial pension buy-out involving the purchase of a group 
annuity contract for GM’s salaried retirees who retired before December 1, 2011 and refused a 
lump sum offer in 2012. To the extent retirees accepted a lump sum payment in lieu of future 
pension payments, the longevity risk was transferred directly to the retiree.18 The deal was 
classified as a partial buy-out rather than a buy-in because it involved the settlement of the 
obligation. In other words, the portion of the liabilities associated with the annuity contract will 
no longer be GM’s obligation. Moreover, in contrast to a buy-in, the annuity contract will not 
be an asset of the pension plan, but instead an asset of the retirees. In October 2012, GM did a 
$3.6 billion buy-out of the pension obligations of its white-collar retirees. Also in October 
2012, Verizon Communications executed a $7.5 billion bulk annuity buy-in with PICA. The 
buy-out deals in the U.S. in 2012 amounted to $36 billion.  
 
The eighth conference (L8) was held at the University of Waterloo, Ontario, Canada on 7-8 
September 2012.19 
 
In February 2013, the first medically underwritten bulk annuity (MUBA) transaction was 
executed in the UK by the UK insurer Partnership.20 This involved each member filling in a 
medical questionnaire in order to get a more accurate assessment of their life expectancy based 
on their medical history or lifestyle. This was particularly useful in the case of ‘top slicing’, 
where scheme trustees insure the pensioners (who will typically be the company directors) with 
the largest liabilities and who therefore represent a disproportionate risk concentration for the 
scheme. In December 2014, Partnership executed a £206m medically underwritten bulk 
annuity transaction with a ‘top slicing’ arrangement for the £2bn Taylor Wimpey pension 
                                                 
17 The conference proceedings for L7 were published in the September 2013 issue of the Journal of Risk and 
Insurance. 
18 In fact, the lump sum was only being offered to limited cohorts of plan members. 
19 The conference proceedings for L8 were published in the North American Actuarial Journal (Volume 18(1), 
2014). 
20 Harrison and Blake (2013). 
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scheme. UK insurer Legal & General (L&G) transacted a £230m medically-underwritten buy-
in in December 2015. The process of collecting medical information has been streamlined in 
recent years using third-party medical data collectors, such as MorganAsh, Age Partnership 
and Aon’s AHEAD platform. It is expected that the share of medically underwritten de-risking 
deals will increase significantly over the next few years in the UK, with new business more 
than doubling from £540m in 2014 to £1,200m in 2015.21 In April 2016, the two largest UK 
medical underwriters, Partnership and Just Retirement merged to form the Just Group valued 
at £16bn. 
In April 2013, L&G reported its first non-UK deal, the buy-out of a €136m annuity book from 
New Ireland Life. In June 2013, the Canadian Wheat Board executed a C$150m pension buy-
in from Sun Life of Canada, involving inflation-linked annuities, while in March 2014, an 
unnamed Canadian company purchased C$500m of annuities from an insurer reported to be 
Industrial Alliance, making it the largest ever Canadian pension risk transfer deal to date.  
In August 2013, Numerix, a risk management and derivatives valuation company, introduced 
a new asset class called ‘life’ on its risk modeling platform (in addition to equities, bonds and 
commodities). In November 2013, SPX Corp. of Charlotte, NC, purchased a buy-out contract 
with Massachusetts Mutual Life Insurance Co as part of a deal that moved $800m in pension 
obligations off SPX’s balance sheet.  
The ninth conference (L9) was held in Beijing, China on 6-7 September 2013.22 
In September 2013, UK consultant Barnett Waddingham launched an insurer financial strength 
review service which provides information on an insurer’s structure, solvency position, credit 
rating, and key risk’s in their business model. This service was introduced in response to 
concerns about the financial strength of some buy-out insurers. 
In November 2013, Deutsche Bank introduced the Longevity Experience Option (LEO). It is 
structured as an out-of-the-money call option spread on 10-year forward survival rates and has 
a 10-year maturity. The survival rates will be based on males and females in five-year age 
cohorts (between 50 to 79) derived from the England & Wales and Netherlands LLMA 
longevity indices. LEOs will be traded over-the-counter under a standard ISDA23 contract. 
They allow longevity risk to be transferred between pension funds, insurance companies and 
investors. They are intended to provide a cheaper and more liquid alternative to bespoke 
longevity swaps which are generally costly and time consuming to implement. Purchasers of 
the option spread, such as a pension fund, will gain if realized survival rates are higher than the 
forward rates, but the gains will be limited, thereby providing some comfort to the investors 
providing the longevity hedge. The 10-year maturity is the maximum that Deutsche Bank 
believes investors will tolerate in the current stage in the development of a market in longevity 
risk transfers. It was reported that Deutsche Bank executed its first LEO transaction with an 
ILS fund in January 2014.  
                                                 
21 Hunt and Blake (2016). 
22 The conference proceedings for L9 were published in Insurance: Mathematics and Economics (Volume 63 
(July), 2015). 
23 https://www.isda.org/ 
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In December 2013, Aegon executed a second longevity risk transfer to capital markets 
investors and reinsurers, including SCOR. Société Générale was the intermediary in the €1.4 
billion deal and Risk Management Solutions (RMS) was the modelling agent. 
Also in December 2013, the Joint Forum reported on the results of its consultation on the 
longevity risk transfer market. It concluded that this market is not yet big enough to raise 
systemic concerns, but ‘their massive potential size and growing interest from investment 
banks to mobilize this risk make it important to ensure that these markets are safe, both on a 
prudential and systemic level’ (Joint Forum (2013, p.2)).  
 
In February 2014, the Mercer Global Pension Buy-out Index was introduced. It shows the 
benchmark prices of 18 independent third-party insurers in the four countries with the greatest 
interest in buying out DB liabilities: UK, US, Canada and Ireland. Costs were highest in the 
UK where the cost of insuring £100m of pension liabilities was 123% of the accounting value 
of the liabilities – equivalent to £32 per £1 p.a. of pension.24 The comparable costs in Ireland, 
the U.S. and Canada were 117%, 108.5% and 105%, respectively. The higher cost in the UK 
is in part due to the greater degree of inflation uprating in the UK compared with the other 
countries. The difference between the US and Canada is explained by the use of different 
mortality tables. Rising interest rates and equity markets will lower funding deficits and hence 
lead to lower buy-out costs in future, especially in the US.  
 
In July 2014, Mercer and Zurich launched Streamlined Longevity Solution, a longevity swap 
hedge for smaller pension schemes with liabilities above £50m. This is part of a new Mercer 
SmartDB service which provides bespoke longevity de-risking solutions and involves a panel 
of reinsurers led by Zurich. It reduces the costs by having standardized processes for 
quantifying the longevity risk in each pension scheme. The first deal, valued at £90m, was 
transacted with an unnamed UK pension scheme in December 2015.  
 
The tenth conference (L10) was held at Universidad Diego Portales in Santiago, Chile on 3-4 
September 2014.25 
 
In December 2014, Towers Watson launched Longevity Direct, an off-shore longevity swap 
hedging service that gives medium-sized pension schemes with liabilities between £1-3bn 
direct access to the reinsurance market, via its own cell (or captive) insurance company. This 
allows schemes to bypass insurers and investment banks, the traditional de-risking 
intermediaries, and significantly reduces transactions costs and completion times, while still 
getting the best possible reinsurance pricing. The first reported transaction on the Longevity 
Direct platform was the £1.5bn longevity swap executed by the Merchant Navy Officers 
Pension Fund (MNOPF) in January 2015 which was insured by MNOPF IC, a newly 
established cell insurance company based in Guernsey, and then reinsured with Pacific Life 
Re. In February 2015, PwC launched a similar off-shore longevity swap service for pension 
schemes as small as £250m. It used a Guernsey-based incorporated cell company called Iccaria, 
established by Artex Risk Solutions, to pass longevity risk directly on to reinsurers. The 
arrangement is fully collateralized and each scheme owns a cell within Iccaria which again 
avoids the costs of dealing with insurer and investment bank intermediaries. 
 
                                                 
24 Towers Watson (2015) Corporate Briefing, April. 
25 The conference proceedings for L10 were published in the Journal of Risk and Insurance, Volume 84, 
Number S1, April 2017, 273-532. 
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There is increasing demand from reinsurance companies for exposure to large books of pension 
annuity business to offset the risk in their books of life insurance. For example, in 2014, Warren 
Buffett’s Berkshire Hathaway agreed to a £780m quota-reinsurance deal with the Pension 
Insurance Corporation (PIC), a specialist UK buy-out insurer.26 Similarly, in August 2014, 
AXA France executed a €750m longevity swap with Hannover Re.  
 
In March 2014, L&G announced the biggest single buy-out in the UK to date when it took on 
£3bn of assets and liabilities from ICI’s pension fund, a subsidiary of AkzoNobel. In December 
2014, L&G announced the largest ever UK buy-in valued at £2.5bn with US manufacturer 
TRW. Around £13bn of bulk annuity deals were executed in the UK in 2014, the largest volume 
of business since the de-risking market began in 2006 and beating the previous best year of 
2008, just before the Global Financial Crisis, when £7.9bn of deals were completed. The total 
volume of de-risking deals in the UK in 2014 (covering buy-outs, buy-ins and longevity swaps) 
was £35bn, a significant proportion of which is accounted for by the £16bn BT longevity swap.  
 
In November 2014, the Longevity Basis Risk Working Group (2014) of the Institute and 
Faculty of Actuaries (IFoA) and LLMA published ‘Longevity Basis Risk: A Methodology for 
Assessing Basis Risk’. This study develops a new framework for insurers and pension schemes 
to assess longevity basis risk. This, in turn, will enable simpler, more standardized and easier 
to execute index-based longevity swaps to be implemented. Index-based longevity swaps allow 
insurers and pension schemes to offset the systematic risk of increased liabilities resulting from 
members living longer than expected. It had hitherto been difficult to assess how effectively an 
index-based longevity swap could reduce the longevity risk in a particular insurance book or 
pension scheme. The methodology developed in the report is applicable to both large schemes 
(which are able to use their own data in their models) and smaller schemes (by capturing 
demographic differences such as socio-economic class and deprivation).  
 
In March 2015, the UK government announced that it would introduce a new competitive 
corporate tax structure to allow ILS to be domiciled in the UK and the associated Risk 
Transformation Regulations 2017, creating a new regulated activity of insurance risk 
transformation, came into effect in December 2017.  In May 2015, Rothesay Life, the 
insurance company owned by Goldman Sachs, bought out the liabilities of Lehman Brothers' 
UK pension scheme for £675m, thereby securing the pensions of former employees of the 
company associated with the beginning of the Global Financial Crisis. In April 2016, Rothesay 
bought two-thirds of Aegon’s UK annuity book – representing 187,000 policy holders – for 
£6bn, bringing total assets under management to £20bn and total lives assured to over 400,000. 
This was the first substantial annuity transfer since the introduction of Solvency II in January 
2016. This new solvency regime for EU-based insurers increased capital requirements and has 
reduced the attractiveness of annuities as a business line for certain insurers and raised buy-out 
prices by 5-7%.27 
 
In 2015, L&G entered both the US and European pension risk transfer markets. It executed a 
$450m transaction with the US subsidiary of Royal Philips covering 7,000 scheme members 
in October and a €200m deal with ASR Nederland NV, a Dutch insurer in December. The 
pension obligations were transferred to L&G Re in cooperation with Hannover Re. L&G said: 
‘The pension risk transfer market has become a global business…The potential market for 
pension risk transfer in the US, UK and Europe is huge, and will play out over many decades’. 
                                                 
26 Reported in Financial News, 14 July 2014. 
27 Financial News, 28 March–3 April 2016 
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Two US insurers were also involved in the Royal Philips deal: PICA also acquired $450m of 
scheme liabilities covering another 7,000 members, while American United Life Insurance 
Company issued annuity contracts to 3,000 deferred scheme members, valued at $200m. 
 
In January 2015, the Bell Canada Pension Plan executed a C$5bn longevity swap with Sun Life 
Financial,28 SCOR, and RGA Re; it was SCOR’s first transaction in North America. In the 
process, Canada became the first country apart from the UK to have all three pension risk 
transfer solutions actively in use. In the same year, it completed its first inflation-linked buy-
in annuity transaction, while in 2017, it completed its first buy-in annuity covering active future 
benefits.29 In June 2015, Delta Lloyd did a second €12bn longevity swap with RGA Re: the 
swap was also index-based, with an 8-year duration and had a notional value of €350m.30 In 
July 2015, Aegon executed one valued at €6bn with Canada Life Re, a new entrant to the de-
risking market in 2015. Another new entrant was Scottish Widows. 
 
In June 2015, the Mercer Pension Risk Exchange was launched. It gives clients in the US, UK 
and Canada up to date buy-in and buy-out pricing based on their plan’s data. It collects prices 
provided monthly by insurers in the bulk market, based on plan benefit structures and member 
data. Mercer said: ‘Many companies have the appetite to transfer pension risk off their balance 
sheet, but they face barriers: lack of clear information about the true cost of a buy-in or buy-
out, limited transparency, the fluctuation of market rates and plan economics to name but a 
few. [The exchange will enable] sponsoring employers and trustees to be more strategic and 
sophisticated in their approach and to know that they are executing a buy-in or a buy-out at the 
best time for them and at a competitive price’. 
 
The eleventh conference (L11) was hosted by Université Lyon 1, Lyon, France on 7-8 
September 2015.31 
 
In April 2016, WTW released PulseModel which uses medical science and the opinions of 
medical experts to improve longevity predictions. For example, the model predicts that 16% of 
50-year-old men in the UK will develop type-2 diabetes in the next 20 years, but this rises to 
50% for those who are both obese and heavy smokers. Overall, the model predicts that 
longevity improvements in the future will be lower than currently predicted, at around 1% p.a. 
rather than 1.5%. If this turned out to be correct, then the current price of longevity of risk 
transfer products would be too high.  
 
The largest buy-in in 2016 (in December) was Phoenix Life’s £1.2bn buy-in for the 4,400 
pensioners in the PGL Pension Scheme, which is sponsored by the Phoenix Group, Phoenix 
Life’s parent company. This replaced a longevity swap that it had set up for the plan in 2014. 
This is the first example of a transaction which transforms a longevity swap into a bulk annuity. 
Phoenix Life saw this as an opportunity to bring £1.2bn of liquid assets (mostly UK 
government bonds) onto its balance sheet, which could then be swapped into a higher yielding, 
matching portfolio, structured to maximize the capital benefit under Solvency II. This, in turn, 
meant that Phoenix Life would be assuming the market risks associated with the PGL scheme 
pension liabilities in addition to the longevity risks – and already does this on its existing book 
                                                 
28 Sun Life Financial uses the RMS Longevity Risk Model, which RMS describes as a ‘structural meta-model of 
geroscience advancement’. 
29 Eckler Consultants (2017) Pension Risk Transfer Report, November. 
30http://www.artemis.bm/blog/2015/06/26/delta-lloyd-rga-in-second-e12-billion-longevity-swap-deal/ 
31 The conference proceedings for L11 were published in Insurance: Mathematics and Economics, 78 (2018), 
157–380.  
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of individual annuities which are backed by £12bn of assets.  The timing was also critical. 
Phoenix wanted to ensure that its internal model under Solvency II had bedded down well and 
that the capital and balance sheet impacts of the transaction were well understood, and that 
Phoenix had elicited the full support of the UK Prudential Regulation Authority (PRA)32 for 
the transaction, thereby ensuring execution certainty. Phoenix also provided comfort to the 
plan’s trustees by giving them ‘all-risks' cover from point of buy-in (‘all-risks' cover is not 
usually provided until buy-out) and strong collateral protection.33 
2016 saw the beginning of a trend towards consolidation amongst insurance companies 
involved in the longevity risk transfer business in the UK. For example, Aegon sold its £9bn 
UK annuity portfolio to Rothesay Life and L&G between April and May, as part of a strategy 
to free up capital from non-core businesses. Part of the reason for this is the additional capital 
requirements under Solvency II. Similarly, in September, Deutsche Bank sold its Abbey Life 
subsidiary to Phoenix Life – a consolidator of closed insurance books – for £935mn, as part of 
a planned programme of disposals aimed at restoring its capital base. There is an estimated 
£100bn of UK individual annuities in back books and further consolidation of these back books 
is anticipated. In December 2017, L&G sold its £33bn closed book of traditional insurance-
based pensions, savings and investment policies to the ReAssure division of Swiss Re for 
£650m. 
Solvency II has also been blamed for some companies pulling out of the bulk annuities market 
altogether, a key example being Prudential (UK) in January 2016. Prudential (UK) announced 
it would be selling a portion of its £45bn UK annuity and pension liability businesses due to an 
inadequate return on capital and to transfer that capital to its growing businesses in Asia.34 
Reinsurance deals have also increased in response to Solvency II, involving non-EU reinsurers. 
For example, PIC executed a £1.6bn longevity reinsurance agreement with PICA in June 2016.  
2016 also witnessed the increasing streamlining and standardization of contracts. This is 
particularly beneficial to small plans below £100m. Previously, smaller plans have been less 
attractive to insurers due to the higher costs of arranging such deals relative to the profit earned. 
To circumvent this, consultants have begun offering services that allow smaller plans to access 
improved pricing and better commercial terms using a standardized off-the-shelf process 
incorporating pre-negotiated legal contracts. Pricing is more competitive because the insurer’s 
costs are kept low. An example is Willis Towers Watson’s Streamlined Bulk Annuity Service. 
The increasing maturity of the market has meant that some larger plans have also been prepared 
to use pre-negotiated contracts. 
2016 was also the tenth anniversary of the longevity transfer market. Since its beginning in the 
UK in 2006, £40bn of buy-outs and £31bn of buy-ins have taken place in the UK, covering one 
million people.35 Yet this equates to just 5% of the £1.5trn of UK DB pension assets and 3% 
of the £2.7trn of DB pension liabilities on a buy-out basis. In addition, forty eight longevity 
swaps are known to have been completed in the United Kingdom between 2007 and 2016, 
valued at £75bn and covering 13 insurance companies’ annuity and buy-out books, 22 private 
sector pension funds, and one local authority pension fund (some of which executed more than 
                                                 
32 This is the regulatory authority for insurance companies in the UK. 
33 Stephanie Baxter (2017) How PGL's longevity swap was converted into a buy-in, Professional Pensions, 10 
April. 
34 https://www.ftadviser.com/pensions/2016/12/05/prudential-seeks-buyers-for-45bn-annuity-business/ 
35 LCP, Professional Pensions (15 December 2016 and 26 January 2017). Since 2007, some 92 buy-ins have been 
completed. 
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one swap).36 Figure 1 shows the growth of the global market in longevity risk transfer between 
2007 and 2018. A total of $434bn in transactions have been completed during this period.  
 
The twelfth conference (L12) was held in Chicago on 29-30 September 2016 and hosted by the 
Society of Actuaries and the Pensions Institute.37 
At the beginning of 2017, there were eight UK-domiciled insurers actively participating in the 
pension risk transfer market in the UK. The largest players are PIC and L&G, with market 
shares of 37% and 30%, respectively. The others are Rothesay Life, Canada Life, Zurich, 
Scottish Widows, Standard Life, and new entrant Phoenix (since August). Occasionally, the 
insurers co-operate in a transaction. To illustrate, in August 2017, L&G executed a longevity 
swap in respect of £800m of the pension liabilities of Scottish and Southern Energy (SSE), 
while PIC completed a £350m buy-in for the company. Consultant LCP estimated that £12bn 
buy-ins and buy-outs took place in 2017 and £19bn took place in 2018, with total insurer 
capacity at £25bn: ‘There remains significant capacity and competition – even if a large back-
book comes to market – providing attractive opportunities for pension plans to transfer 
longevity risk through a buy-in or buy-out’.38  
 
 
                                                 
36 www.artemis.bm/library/longevity_swaps_risk_transfers.html; see Table A2 for a full list of UK publicly 
announced longevity swaps between 2007 and 2016. 
37 The conference proceedings for L12 were published in the North American Actuarial Journal.  
38  https://www.lcp.uk.com/media-centre/press-releases/2017/08/buy-in-and-buy-out-volumes-nearly-double; 
LCP (2018) Pension De-risking 2018.  
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Figure 1:  Cumulative Pension Risk Transfers by Product and Country, $bn, 2007-2019 
 
 
 
 
 
       
Data in USD billions. Cumulative totals. Sources: LIMRA, Hymans Robertson, LCP, WTW and Prudential Financial, Inc. (PFI) analysis of EY, 31 December 
2019. 
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One of the largest deals in 2017 (in September) involved a £3.4bn longevity swap between 
the Marsh & McLennan Companies (MMC) UK Pension Fund and both Canada Life 
Reinsurance and PICA, using Guernsey-based incorporated cell companies, Fission Alpha 
IC Limited and Fission Beta IC Limited. MMC subsidiary Mercer led the transaction as 
adviser to the pension fund trustee and the deal was the first to be completed using the 
Mercer Marsh longevity captive solution, with no upfront premium. The two reinsurers 
shared the risk equally and the use of the captive ICC vehicle meant that no insurer 
intermediary was required, making the deal more cost-effective for the pension fund.39 
Also in September, the British Airways’ Airways Pension Scheme used a similar 
Guernsey-based captive insurer to set up a £1.7bn longevity swap. The longevity risk was 
then reinsured with Partner Re and Canada Life Re. The scheme had previously hedged 
£2.6bn of liabilities through two longevity swap transactions executed by Rothesay Life in 
2010 and 2011.40  In November 2017, PIC executed a £900m longevity swap with PICA, 
while in December 2017, L&G executed a £600m longevity swap with PICA.41 
In December 2017, NN Life, part of the Nationale-Nederlanden Group, executed an index-
based longevity hedge with reinsurer Hannover Re, in a deal covering the insurer against 
the longevity trend risk in €3bn of its liabilities. The structure is similar to the 2013 Aegon 
tail-risk deal arranged by Société Générale and builds on subsequent work including 
Michaelson and Mulholland (2015) and Cairns and El Boukfaoui (2018). While the term 
of the transaction is 20 years, NN Life is protected over a longer time period via a 
commutation function42 that applies at maturity. If longevity improvements have been 
much stronger than expected, this will be assumed to continue until the liabilities run-off 
and NN will receive a payment under the hedge. The transaction helped to reduce the 
solvency capital requirement of NN’s Netherlands life business by €35m. The index 
attachment point for the hedge is close to NN’s best estimate, which helps maintain the 
SCR relief and effective risk transfer over time.43, 44    
 
In order to reduce the costs of de-risking, pension plans are encouraged to perform some 
liability reduction exercises, the key ones being:45 
                                                 
39 http://www.artemis.bm/blog/2017/09/14/mmc-pension-offloads-huge-3-4bn-of-longevity-risk-to-
reinsurers. The counter to this cost-effectiveness is that the hedger takes on additional counterparty risk. If a 
reinsurer fails then there is no insurer to protect MMC's pension scheme.  
40 Nick Reeve (2017) BA scheme uses ‘captive insurer’ in £1.6bn longevity risk hedge, IPE, 13 September. 
41 https://www.pensioncorporation.com/media/press-releases/Prudential, PIC Reach $1.2 Billion Longevity 
Reinsurance Agreement; L&G reinsures £600m of longevity risk through Prudential, Professional Pensions, 
21 December 2017. 
42 The role of the ‘commutation function’ is to ‘compress’ the risk period. As explained in Michaelson and 
Mulholland (2015, pp.32-33): ‘This is accomplished by basing the final index calculations on the 
combination of two elements: (i) the actual mortality experience, as published by the national statistical 
reporting agency, applied to the exposure defined for the risk period; and (ii) the present value of the 
remaining exposure at the end of the risk period calculated using a ‘re-parameterized’ longevity model that 
takes into account the realized mortality experience over the life of the transaction’. 
43 http://www.artemis.bm/blog/2017/12/01/nn-life-gets-index-based-longevity-hedge-from-hannover-re/ 
44 https://www.nn-group.com/Investors/Capital-Markets-Day-2017.htm 
45 Professional Pensions (2016) Risk Reduction and the Extent of Trust in Pension Scheme Advisers and 
Providers, June, p.26. 
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• Enhanced transfer values (ETVs) – allow deferred members to transfer an uplifted 
value of their benefits to an alternative arrangement. In August 2017, a 64-year old 
entitled to an index-linked pension starting at £10,000 from age 65 would be offered 
a transfer value of £237,000, according to the Xafinity Transfer Value Index.46 In 
October 2019, the transfer value was £244,200. In 2019, around 50,000 members 
transferred out of their DB scheme, around 1% of eligible members.47 
• Flexible retirement options (FROs) – allow deferred members aged 55 and over to 
retire early, or to take a transfer value and secure benefits in a different format from 
their plan benefits, or to use funds for drawdown purposes. 
• Pension increase exchanges (PIEs) – allow pensioners to exchange non-statutory 
increases for a higher immediate pension with lower or even zero future increases 
(e.g., a £10,000 annual pension with inflation uplifting is replaced by a £12,000 
annual pension with no further increases). 
• Trivial commutations (TCs) – allow members with low value benefits to cash these 
in. 
The most common exercises currently in the UK are PIEs and TCs – and these can be 
conducted either before or at the same time as a bulk purchase annuity broking exercise.   
 
Innovation is a continuing feature of this market. Some examples include (see, e.g., Legal 
& General and Engaged Investor, 2016):48 
• Buy-ins and buy-outs with deferred premium payments – to spread costs, schemes 
that cannot afford the upfront premium of a de-risking solution pay for it in 
instalments over a number of years. 
• Buy-outs combined with a longevity hedge.49 
• Phased buy-ins, where the largest risks or the lowest cost risks are insured first. 
• Phased de-risking using a sequence of partial buy-ins with an ‘umbrella’ structure 
to avoid more than one set of contract negotiations – to spread costs. 
• Accelerated buy-ins – the insurer provides a loan to the plan equal to the deficit 
(sometimes called a winding up lump sum (WULS)), so that a partial buy-in can 
take place immediately, with this converting to a full buy-in when the loan has been 
repaid, or with the option of a full buy-out at a later date. 
• Forward start buy-ins – a standard buy-in with the start date delayed to reflect the 
level of funding available, with additional options, such as paying deferred 
members as and when they retire if this is prior to the start date, or the ability to 
bring forward the start date for an additional fee. 
• Self-managed buy-ins – which allows pension schemes to run their own asset 
management strategy at lower cost and with a lighter regulatory burden than if an 
insurer was involved (introduced in 2018 by the UK asset manager Insight 
                                                 
46 Hannah Godfrey (2017) DB transfer values back on the rise in August, Professional Adviser, 7 September. 
47 Sophie Smith (2019) DB transfer values in record fall – XPS, Pensions Age, 7 November. 
48 Legal & General and Engaged Investor (2016) De-risking Journeys of Mid-sized Pension Schemes, June. 
49 An example of this was the Philips Pension Fund which in 2015 completed a full buy-out valued at 
£2.4bn with PIC. The longevity risk was simultaneously reinsured with Hannover Re. Another interesting 
feature of this deal was that it covered both retired and deferred members. 
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Investment). The strategy uses swaps to hedge interest, inflation and longevity risks 
and is estimated to be 10-15% cheaper than the equivalent insurance product.50  
• Automated bulk plan transfers – to reduce risks (introduced in November 2017 by 
Scottish Widows and Standard Life).51 
• Top-slice buy-ins – to target the highest value liabilities. 
• Named-life longevity swap – if the named member lives longer than expected, the 
insurer pays out the difference (examples being the £400m Bentley plan or an 
unnamed plan with 90 named pensioners valued at £50m). 
• Tranching by age – to reduce costs; according to consultant Punter Southall, a buy-
in for pensioners up to age 70 will make a subsequent buy-out within the following 
10 years cheaper than a buy-in for the over 70s.52 
• Longevity swaps for small pension plans with liabilities of £50-100m – previously 
only available for medium (£100-500m) and large plans (above £500m). 
• Novation – the ability to transfer a longevity hedge from one provider to another, 
thereby introducing some liquidity into what had previously been a completely 
illiquid market. An example would be the reinsurance of a small bulk annuity 
transaction. Contract simplicity is a desirable feature of such arrangements. 
• Longevity swap to buy-in conversions – as pioneered by Phoenix Life in December 
2016 for its parent company’s pension plan. Solvency II incentivizes buy-in 
providers to hold longevity insurance, otherwise they pay an additional risk margin.  
This encourages buy-in providers to seek out plans which already have a longevity 
hedge and encourage them to do a buy-in. Another driver is longevity swap 
providers that are not currently active in the market – such as J.P. Morgan and 
Credit Suisse – but are still responsible for running off their existing swaps. They 
might have an incentive to encourage the associated pension plan to novate the 
swap to a buy-in provider and hence extinguish their liability.53 
• Insuring away the extreme tail of liabilities in a closed plan after a specified term, 
such as 5 or 10 years – to reduce costs. 
• Increasing optionality in contracts to improve flexibility – for example, the option 
to switch the indexation measure for pensions in payment from the Retail Price 
Index to the Consumer Price Index if government legislation changes; or the option 
to secure discretionary benefits, such as actual inflation above a 5% cap; or 
surrender options. 
• Insuring the tail of the liabilities – whereby a closed scheme that cannot afford a 
full buy-out insures only the liabilities after a certain point in time, say, 10 years’ 
ahead. 
                                                 
50 Angus Peters (2018) Insurers compete with fund managers for lucrative pension pots, FTfm, 15 January. 
The article points out that ‘insurers and asset managers are engaged in a turf war for the £1.6tn sitting in the 
UK’s defined benefit schemes’. 
51 Michael Klimes (2017) How the first automated bulk scheme transfers happened, Professional Pensions, 
10 November. 
52 James Phillips (2017) DB schemes insuring wrong tranche of members in buy-ins, Professional Pensions, 
14 August. 
53 Stephanie Baxter (2017) Converting longevity swaps into bulk annuities: The next de-risking innovation?, 
Professional Pensions, 13 April. 
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• Combining liability management solutions (such as interest rate and inflation 
swaps, and ETV, FRO and PIE exercises) and bulk annuities in a buy-out – so 
instead of completing liability management before considering a buy-out, plans do 
this in a single exercise. 
• ‘Buy-out aware’ investment portfolios – used to reduce buy-out price volatility and 
close the funding shortfall, with the buy-out price locked to the value of the buy-
out aware funds once a target shortfall has been reached and whilst the contract 
documentation for a buy-out is being completed. 
• Improved arrangements for handling data errors that arise after a deal has been 
executed – to reduce pre-deal negotiation requirements and post-deal transaction 
uncertainty. Common data errors include member gender, date of birth, and benefit 
amounts for both member and partner. A simplified data error process could deal 
with these issues in the following way: locking down benefits, removing the need 
for re-pricing; mechanistically adjusting demographic errors; and using due 
diligence to check for systematic errors with the data.54 
• Residual risk insurance, covering, e.g., benefit specification errors, data errors, and 
unidentified beneficiary cover. 
• Arrangements to handle deferred members – to improve insurer appetite to assume 
the additional risk and cost involved. Deferred lives make up almost half (45%) of 
the membership of UK DB plans in the UK.55 They are much more expensive to 
hedge for a number of reasons. First, there can be problems with their existence and 
identification. Second, they enjoy a large number of options which need to be 
priced.56 Third, their longevity risk is greater, because the longevity improvement 
assumption used for pricing has greater reliance on the assumed long-run trend.57 
Fourth, as a direct consequence of the previous points, more capital is needed and 
this, in turn, increases the demand for reinsurance. These issues can be at least 
partially mitigated as follows: a robust existence checking procedure is needed 
involving electronic tracing, assuming a fixed percentage of the pension is 
exchanged for tax-free cash, setting the assumed retirement date to the plan’s 
normal retirement date, assuming no pension is exchanged for additional partner 
pension, restricting the age profile to older deferred members, and restricting the 
proportion of deferred members in the transaction.58 
 
                                                 
54 Andrew Murphy (2017) Developments in longevity swaps, Pacific Life Re, 23 November, IFoA Life 
Conference.  Provided due diligence has been carried out at the outset, subsequent data errors tend to be 
unbiased in terms of their impact and so average out close to zero. 
55 That is 4.9m members (The Pension Regulator and the Pension Protection Fund, Purple Book 2015). 
56 For example, lump sum commutation, trivial commutation, early/late retirement, increasing a partner’s 
benefits at the expense of the member’s benefits, and pension increase exchanges. 
57 Valuation and risk assessment of a deferred annuity can be broken down into five overlapping components: 
survival to retirement; the socio-economic group of the pensioner at the date of retirement; the base mortality 
table at the time of retirement for that socio-economic group; general mortality improvements (e.g., age 65+) 
up to the date of retirement; and the mortality improvement rate after retirement. Uncertainty in the 
probability of survival to retirement will typically be quite small in relation to the other risks. 
58 Andrew Murphy (2017) Developments in longevity swaps, Pacific Life Re, 23 November, IFoA Life 
Conference. 
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These are all innovations in the space linking pension plans and insurance companies 
designed to ease the transfer of pension liabilities (or at least the longevity risk in them) 
from pension plans to insurance companies.  
 
The innovations have helped to encourage more business, but this is, in turn, has exposed 
potential longer term capacity constraints within insurance companies. As one consultant 
said: ‘Given the market has historically completed only 150-200 deals in any one year, 
there is a real risk of capacity constraints in the market, not just from an insurer capital 
perspective, but also from a resource and expertise perspective’.59  
 
A total of £12.4bn in buy-ins and buy-outs and £.6.4bn in longevity swaps took place in 
the UK in 2017. 
 
In April 2015, the UK government introduced ‘Freedom and Choice’ pension reforms 
which gave more flexibility to how individuals could draw down their defined contribution 
(DC) pension pots.60 In particular, there was no longer a requirement to purchase an 
annuity.61 This immediately led to a fall in annuity sales by around 75% (Cannon et al 
(2016)). The situation was not helped by the fall in gilt yields (which led to a corresponding 
fall in annuity rates) arising from the government’s quantitative easing programme 
introduced after the Global Financial Crisis. In August 2017, a 65-year old with a £100,000 
pension pot, could get a level income for life of £4,894: two years before, the amount would 
have been £5,292.62 By 2017, the following insurers had pulled out of the open market for 
annuities: Aegon, LV=, Partnership (before it merged with Just Retirement to form Just 
Group), Prudential (UK), Standard Life, Friends Life (merged with Aviva), Reliance 
Mutual, B&CE, and Retirement Advantage. This leaves just six providers left in what was 
once the world’s largest annuity market: Aviva (offering standard and enhanced annuities), 
Canada Life (standard and enhanced), Hodge Lifetime (standard only), Just Group 
(enhanced only), L&G (standard and enhanced) and Scottish Widows (standard and 
enhanced).63  
 
In place of annuities, individuals took their pension pot either as a lump sum or they 
purchased an income drawdown product. In both cases, they bear their own longevity risk. 
Evidence shows that people systematically underestimate their life expectancy which 
implies that there is a significant probability that many people will spend their pension pot 
                                                 
59 Martyn Phillips, Mercer (quoted in Professional Pensions (2016) Risk Reduction and the Extent of Trust 
in Pension Scheme Advisers and Providers, June, p.28). Hannover Re had previously warned about this: ‘The 
number of risk-takers is limited and there is no unlimited capacity in the market for taking on longevity risk. 
The increasing worldwide demand for longevity cover will challenge the capacity for securing longevity risk’ 
(quoted in Punter Southall (2015) De-risking Bulletin, March). At the time of writing, there were significant 
human resource bottlenecks in some parts of the transaction chain, in particular, a shortage of qualified 
lawyers. 
60 The proposal was announced by the UK finance minister (George Osborne) in his Budget Speech on 19 
April 2014. 
61https://www.pensionsadvisoryservice.org.uk/about-pensions/pension-reform/freedom-and-choice 
62 Josephine Cumbo (2017), Pensioners hit as annuity rates drop 10% in two years, Financial Times, 1 
September. 
63  Source: Hargreaves Lansdown, August 2017. Scottish Widows introduced a standard annuity in 
September 2019. 
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before they die. A recent study by Just Group found that UK men aged 40-54 expect to live 
until 78.9 years on average, whereas official estimates of their life expectancy is 87.5; the 
figures for women are 80.5 and 90.1.64  
 
A number of UK insurers providing bulk annuities for buy-ins are also involved in the UK 
equity release mortgage (ERM, or reverse mortgage or lifetime mortgage) market which 
allows home owners to borrow against the equity in their homes. The modern form of the 
market began when the Equity Release Council (ERC) representing providers was 
established in 1991 with a voluntary code of conduct that offered a number of guarantees. 
Before this, users of the product could lose their homes when the value of the loan plus 
interest exceeded the value of the property. Since 1991, there is a guaranteed right to remain 
living in the property, either for life or until entry into long-term care. In addition, there is 
a No Negative Equity Guarantee (NNEG) which means that the value of the loan plus 
interest can never exceed the value of the property, and so no debt can be passed on to the 
estate of the equity release borrower. The providers in the new market therefore face 
longevity risk in a way that those in the old market did not. In 2017, a total of £3bn in 
equity release loans were made with an average size loan of £102,000. In 2018, the UK 
Prudential Regulation Authority (2018) raised concerns that providers were not properly 
reflecting the cost of the NNEG in their capital reserving. Instead of valuing the NNEG 
using the Black (1976) model as a series of put options on the forward house price (which 
is lower than the current price to reflect the loss of rent due to deferred possession) 
weighted by the probability of mortality, morbidity and pre-payment, it pointed out that 
most providers were using the expected future price which required assumptions about 
property growth. 
 
There were also important developments outside the UK in 2017, although many of these 
involve innovations adopted from the UK market. Apart from the US, Canada, and the 
Netherlands, new markets include Germany, Switzerland and Ireland. Examples of 
innovations in the US include: plan-specific mortality data – with $250m as the minimum 
transaction size; asset-in-kind premium funding – where bonds are used to fund the 
transaction. Insurer capacity has also increased, with 14 insurers engaged in pension buy-
outs. Three new insurers joined: Athene,65 Mutual of America, and CUNA Mutual. Athene 
wrote more than $2bn of business in 2017. A total of $24.7bn pension risk transfers were 
conducted in the US in 2017. In Canada, group annuity sales amounted to C$3.7bn, and a 
new group annuity provider, Brookfield Annuity, joined the market. In Germany, many 
schemes are considering using lump sum settlement payments to pensioners to transfer 
longevity risk. In Switzerland, insurers are now willing to consider transfers involving 
active members. In Ireland, Danske Bank transferred €335m of its Irish DB pension 
liabilities to Irish Life.66 
 
                                                 
64 Chris Seekings (2018) Millions of Brits underestimating their life expectancy by a decade, The Actuary, 
3 May. There were similar findings in a study by the Institute for Fiscal Studies, see James Phillips (2018) 
New retirees overly pessimistic about life expectancy, Professional Pensions, 17 April. 
65 Athene is majority owned by private equity company Apollo Global Management, LLC. 
66 Navigating you through your de-risking journey: Overseas, Aon Risk Settlement Market Review 2018. 
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In April 2017, the International Monetary Fund (IMF) released a new edition of its Global 
Financial Stability Report. Chapter 2 (‘Low Growth, Low Interest Rates, And Financial 
Intermediation’) suggests that DB pension funds across the globe might have to cut benefits 
‘significantly’ in the long term because of ultra-low interest rates. Attempts to increase 
returns by changing asset allocations ‘appears feasible only by taking potentially 
unacceptable levels of risk’. In the face of such low rates, the IMF argues that ‘life insurers 
and pension funds would face a long-lasting transitional challenge to profitability and 
solvency, which is likely to require additional capital’ or would require a ‘very high’ level 
of volatility risk to meet their funding goals. However, a combination of risk aversion and 
regulatory constraints was likely to deter the vast majority from taking this second path. 
The IMF instead believes that the current situation might work to the benefit of insurers 
backing buy-ins and buy-outs. With investors increasingly monitoring the size of DB 
liabilities and the effects on company share prices, profits, and dividends, the IMF said 
offloading these liabilities to insurers ‘is an attractive option’ and ‘may represent a market-
efficient arrangement’ and that ‘regulation could play an important role in this area by 
facilitating such transactions’. 
 
The thirteenth conference (L13) was held in Taipei, Taiwan on 21-22 September 2017. It 
was hosted by the Department of Risk Management and Insurance and the Risk and 
Insurance Research Center at National Chengchi University, and by the Pensions Institute 
at Cass Business School.67 
 
2018 saw the start of a trend towards consolidation amongst pension schemes in the UK. 
This was led by a group of private equity investors. One example is the Pension Superfund 
which was launched in March with capital provided by Disruptive Capital and Warburg 
Pincus. It promises employers a cheaper way to offload their pension obligations than a 
traditional insurance buy-out. Any surplus of assets above 115% of liabilities ‘on a prudent 
actuarial basis’ will be shared one-third to members and two-thirds to the investors. The 
liabilities would be hedged and the investment strategy would be ‘fairly low risk’. The 
Pension Superfund would be initially targeting schemes with assets between £200m-£1bn 
with a strong sponsor covenant. Another example is Clara. Insurers have expressed 
concerns that since such pension consolidation vehicles come under the Pensions Regulator 
(i.e., are classified as pension schemes) they do not have to satisfy the much stricter 
solvency requirements of insurers which are regulated by the Prudential Regulation 
Authority (PRA), which is part of the Bank of England.68 As of the end of 2019, no deals 
involving either the Pension Superfund or Clara had been completed, since both 
organisations were still awaiting regulatory approval and the government was still 
considering an authorisation, supervision and solvency regime.69  
 
The General Data Protection Regulation (GDPR) was introduced in all EU member states 
in May 2018 and will affect longevity risk transfers since they involve the exchange of 
                                                 
67 The conference proceedings for L13 were published in the North American Actuarial Journal.  
68 James Phillips (2018) The Pension Superfund to split surplus with members and capital providers, 
Professional Pensions, 12 July.  
69 James Phillips (2019) Clara: ‘Shadow market’ is huge for DB consolidation, Professional Pensions, 22 
October. 
  20 
personal data. There are fines for data protection breaches. The GDPR distinguishes 
between data controllers – people who determine how and why data should be used – and 
data processors – who process data on behalf of data controllers. Pension scheme trustees 
will be data controllers, as will insurers if they have received personal data in connection 
with a potential buy-out transaction (e.g., if they are conducting a data cleansing or medical 
underwriting exercise). In other cases, insurers might be classified as data processors. 
International data transfers, e.g., in the case where an insurer wants to transfer data to a 
reinsurer located outside the European Economic Area, can only take place if adequate data 
protections are in place. Care needs to be taken even if anonymized data is transferred, 
since it might still be possible to identify the individuals to whom the data relates, e.g., 
company directors might be identified from information about the size of their pension 
benefits and date of birth. 
 
2018 longevity risk transfer highlights for the UK included:70  
• PIC reinsured all its pensioner liabilities (73% of its total exposure) with Partner 
Re in January. It also helped to fund University Partnerships Programme 
acquisitions of student accommodation with index-linked bonds in February.  
• Scottish Widows executed a £1.3bn longevity swap with PICA in February.71 It 
was the last UK insurer to hedge at least some of its longevity risk. It did this to 
reduce its Solvency II capital requirements. 
• Standard Life Aberdeen sold £2.93bn of its annuity back-book to Phoenix in 
February, with the rest of Standard Life Assurance sold to Phoenix in September. 
• Prudential (UK) sold £12bn of its annuity back-book covering 400,000 policies to 
Rothesay Life in March, making Rothesay the UK’s largest specialist annuity 
insurer with more than £37bn of assets and 750,000 lives insured.72  
• In March, Marks & Spencer Pension Scheme executed two buy-ins totalling £1.4bn 
with Aviva and Phoenix covering 15% of its pension liabilities. It was Aviva’s 
largest buy-in to date (at £925m) and Phoenix’s first external buy-in (at £475m). 
• In March, PIC and PICA introduced a ‘flow reinsurance’ system which automates 
the longevity reinsurance element of buy-outs and buy-ins for schemes with 
liabilities below £200m. The system allows PIC to secure a commitment from PICA 
to assume the longevity risk early on in a transaction. 
• In March, employee benefits consultant, JLT, launched a ‘buy-out comparison 
service’ and monitoring tool which allows schemes to upload their own data and 
                                                 
70 There were £24bn of transfers (buy-outs and buy-ins) in the UK in 2018 plus another £7b in longevity 
swaps. The biggest insurers in the market were L&G, PIC, Zurich, Scottish Widows, Aviva, Canada Life, 
Just, Phoenix Life, and Rothesay Life. 
71 Since 2011, PICA has completed more than £32bn in international reinsurance deals, including the 
£16bn deal with the BT Pension Scheme in 2014. 
72 In August 2019, the High Court in London blocked the Prudential-Rothesay transfer on the grounds that 
Rothesay was a ‘relatively new entrant without an established reputation in the business’ and although it 
had solvency ratios at least equal to Prudential’s, ‘it does not have the same capital management policies or 
the backing of a large group with the resources and a reputational imperative to support a company that 
carries its business name if the need were to arise over the lifetime of the annuity policies’ (Susanna Rust 
(2019) High Court blocks £12bn Prudential-Rothesay annuities transfer, IPE, 19 August). In September 
2019, Prudential and Rothesay announced that they would appeal against the decision on the basis that the 
judgement ‘contains material errors of law’ and should be reconsidered. 
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receive regular bulk annuity quotations from eight insurers currently active in the 
market. 
• In April, JLT became the first consultant to implement Club Vita’s longevity 
analytics capabilities which have been incorporated into RiskFirst’s PFaroe 
modelling system for DB plans. This will allow JLT clients to set best-estimate 
longevity assumptions.73 Club Vita data shows that pension schemes can have a 
very different demographic composition compared with the national population, 
with liabilities that could be up to 10% higher or lower as a result of different 
mortality experience.  
• PIC executed a £900m longevity swap with PICA in May, covering 7,500 
pensioners.74 
• In June, Canada Life sold its £2.7bn back book of 155,000 UK life and pension 
savings policies to Scottish Friendly. The company said it wanted to concentrate on 
developing new retirement products following its acquisition of Retirement 
Advantage, an annuity and retirement income specialist, in January.  
• Siemans completed a £1.3bn buy-in of its UK pension liabilities covering 6,000 
members with PIC in July. 
• Aviva executed a £1bn longevity swap with PICA in August. 
• National Grid Electricity Group completed a £2bn longevity swap with Zurich75 
for the Electricity Supply Pension Scheme also in August. 
• In August, L&G entered the small scheme longevity insurance market after 
completing a £300m longevity swap with an unnamed pension fund. The deal had 
a ‘streamlined structure’ with simplified data requirements which helped to keep 
fixed costs down. The swap was later reinsured with SCOR. According to L&G, 
‘the transaction demonstrates that longevity reinsurance is a realistic option for 
most pension schemes, including for trustees whose schemes are not quite at the 
point they can enter into buy-in or buy-out, but want to manage their longevity 
risk’. 
• In September, the British Airways Pension Scheme entered into the UK’s largest 
buy-in agreement to date (at £4.4bn) with Legal & General, covering 60% of 
pensioner liabilities; taking account of the £1.7bn longevity swap agreed in 2017, 
the scheme has now hedged 90% of its longevity risk. 
• The Automobile Association Pension Scheme completed a £351m buy-in with 
Canada Life also in September. 
• In October, the UK pension scheme of Nortel, the Canadian telecoms company 
which became insolvent in 2009, agreed a £2.4bn buy-out deal with Legal & 
General, covering 15,000 pensioners and 7,200 deferred members, thereby 
avoiding entering the UK Pension Protection Fund which takes on the assets and 
liabilities of failed companies. 
                                                 
73 Club Vita is a longevity data analytics company which pools data from over 220 UK DB schemes covering 
2.8m pensioners, approximately one quarter of the total. RiskFirst is a fintech company which launched the 
PFaroe software in 2009 to enable pension funds to manage their asset and liability risks. 
74 This brought the total value of all the deals between the two companies to £4.4bn. 
75 Zurich reinsured a significant proportion of the longevity risk with Canada Life Re. It has executed 
£3.5bn longevity risk transfer deals since it entered the market in 2016. 
  22 
• In December, PIC executed another longevity swap, this time with SCOR, covering 
8,000 pensioners and valued at £1.2bn.76 
 
In April 2018, the PRA said it was concerned that too much longevity risk was being 
transferred offshore through reinsurance arrangements, preferring that more of it be 
retained in the UK. It said it would consider amending Solvency II risk charges to 
encourage greater retention. While it said it understood the need for risk transfer, it said 
that it was concerned that pension assets were being transferred overseas, taking them 
outside of its regulation, so that if an offshore reinsurance firm failed, UK pensioners 
might not get their pensions.77 
Around £42bn longevity risk transfer deals were announced for the UK in 2019.78 XPS 
reported that for a medium-sized scheme, pensioner member transfers used a ‘gilts + 0.3% 
pa’ discount rate to value the liabilities, while for deferred members the discount rate was 
‘gilts – 0.5% pa’.79  Highlights included:  
• In January, PIC invested £125m in Exeter University accommodation in order to 
generate index cash flows to pay its pensioners. 
• In the same month, PIC completed a £425m buy-in with the Co-operative Group’s 
Somerfield Pension Scheme. 
• L&G executed buy-ins with the Pearson Pension Plan (£500m in February), 
Howden Group Pension Plan (£230m in March) and 3i Group (£95m in April). 
• Rothesay completed a buy-in (amount undisclosed) with the Teachers Assurance 
Group Pension Scheme in February, and a £110m buy-out with the Laird Pension 
Scheme in April. 
• Also in April, PIC completed a £1.2bn buy-in with Commerzbank in respect of the 
Dresdner Kleinwort Pension Plan of its UK subsidiary. 
• In May, PIC and Phoenix insured £900m and £460m, respectively, of the liabilities 
of Marks & Spencer’s UK pension scheme. 
• In June, Rolls Royce executed the biggest buy-out to date – at £4.6bn – with L&G, 
covering the benefits of 33,000 pensioners. As part of the deal, a longevity swap 
originally with Deutsche Bank was transferred to L&G – the first time a swap has 
been novated between counterparties. 
• In July, Scottish Widows completed buy-ins totalling £830m with Peugeot and 
QinetiQ 
• In August, PIC executed a £3.4bn de-risking deal with the British American 
Tobacco UK Pension Fund covering both 8,300 pensioners and 2,300 deferred 
members. It is the biggest deal to date covering both retired and non-retired 
members. 
• In August, PICA completed a £7bn longevity swap with banking group HSBC’s 
UK pension scheme – making it the second largest swap in the UK after the £16bn 
                                                 
76 This brought the total value of the deals between the two companies to £2.2bn. 
77 Steve Evans (2018) Bank of England wants more longevity risk retained, less reinsured, Reinsurance 
News, 27 April; https://www.reinsurancene.ws/bank-of-england-wants-more-longevity-risk-retained-less-
reinsured/ 
78 This compares with £1bn when the market started in 2006. 
79 XPS Risk Transfer News, issue 10/19.  
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swap for the British Telecom Pension Scheme in 2014, also arranged by PICA. The 
transaction ‒ which covers half of the scheme’s pensioner liabilities ‒ was 
structured as an insurance contract with a Bermuda-based, HSBC-owned captive 
insurer, which reinsured the longevity risk with PICA. It was the first captive 
longevity reinsurance transaction for a pension scheme associated with a major 
bank. Amy Kessler, PICA’s head of longevity risk transfer, said: ‘The captive 
approach has become the strategy of choice for large pension schemes seeking to 
hedge longevity risk’.80 
• In August, Phoenix Life completed a £1.1bn buy-in of its own DB pension scheme, 
the PGL Pension Scheme. 
• In August, Rothesay Life executed a £520m buy-in with the Cadbury Mondelēz 
Pension Fund, covering 1,900 pensioner members.  
• In August, L&G announced it had completed a buy-in transaction for the UK hybrid 
pension scheme of data and technology company Hitachi Vantara. The deal was 
described as ‘innovative’ since it also took into account the DC elements of the 
scheme. Each member’s retirement benefit is based on the higher of the DB and 
DC pension over their career with Hitachi Vantara. The buy-in was structured to 
maintain this arrangement, allowing deferred members to ‘consider their options’ 
prior to a full buyout.81 
• In September, L&G arranged a £930m buy-in with the Tate & Lyle Pension 
Scheme, covering 4,800 members. 
• In September, Rothesay Life executed an even larger buy-in than the Rolls Royce 
deal – at £4.7bn ‒ with the GEC 1972 Plan, covering 39,000 members split 70-30 
pensioners and deferreds. There is an option for a buy-out at a later date. Hence this 
is known as a ‘buy-in to buy-out deal’. The parent company of GEC is Telent. 
• Also in September, Rothesay Life insured £3.8bn of members’ benefits for the 
Allied Domecq Pension Fund in another buy-in covering around 27,000 pensioners 
and deferred members, spilt 63-37. The parent company of Allied Domecq is the 
Pernod Ricard Group. 
• In October, Rothesay completed a £2.8bn buy-in with the National Grid Pension 
Scheme (Section A). The following month, L&G completed a £1.6bn buy-in with 
the National Grid Pension Scheme (Section B), covering 6,000 pensioner members. 
• In October, Rothesay executed a full buy-in with retailer ASDA (owned by 
Walmart) for £3.8bn, covering 4,800 pensioners and 7,500 deferred members. This 
will convert to a full buy-out in 2020 or 2021 at an additional cost of £800m. 
• In October, Aviva Life and Pensions UK completed a £1.7bn buy-in for the Aviva 
Staff Pension Scheme, covering 1,500 pensioners and 4,300 deferred members. 
• In November, Phoenix completed a £144m buy-in with the Aegon UK Staff 
Retirement and Death Benefit Scheme. 
• In December, Zurich and Hannover Re completed a £800m longevity swap with an 
unnamed FTSE100 company. 
Other UK developments in 2019 included:  
                                                 
80 Susanna Rust (2019) HSBC pension scheme strikes £7bn longevity risk transfer, IPE, 6 August. 
81 Nick Reeve (2019) L&G backs ‘innovative’ buy-in for Hitachi UK pension scheme, IPE, 14 August. 
  24 
• In February, L&G launched Track My Apps, a tracking service provided by fintech 
company Origo, to enable advisers track their clients pension transfers online.  
• £936m of equity release deals in the first quarter with 20,000 households, taking 
out an average of £50,000 in housing wealth. 
• In May, L&G announced the creation of a UK retirement housing business called 
Guild Living which plans to deliver 3,000 new homes over the next five years with 
a gross development value of £2bn.82 The business will contribute the income it 
needs to pay the benefits on its longevity risk transfer business. In August, L&G 
announced it had acquired a site in Walton-on-Thames suitable for building 300 
homes.  
• In June, L&G launched the first pension risk transfer execution platform to be 
driven by blockchain technology. Known as ‘Estua-Re', the technology provides a 
‘single ecosystem capable of driving every stage of the PRT reinsurance value 
chain’, including pricing, claims handling, financial reporting, and collateral. It 
allows multiple parties to transact with each other without the need for an 
intermediary and there will be greater transparency since all parties will have access 
to the latest version of the ledger database.83  
• In August, PICA and the Phoenix Group launched a reinsurance counterparty to 
provide longevity reinsurance for insurers in the UK pension risk transfer market, 
covering both their buy-out and buy-in transactions. Phoenix head of bulk annuities 
Justin Grainger said: ‘Phoenix views longevity reinsurance as a key risk 
management tool. This transaction brings further depth to our reinsurer 
relationships and enhances our ability to offer competitive terms to pension 
schemes as we continue to develop our de-risking proposition.’ Prudential 
Financial head of international transactions for longevity risk transfer Rohit Mathur 
said: ‘[PICA] has consistently focused on supporting the entire UK pension de-
risking market. The addition of Phoenix is a culmination of our efforts over the past 
several years to do just that. We have invested in our pricing and transaction teams 
and …and we are happy to be in a position to support the robust pipeline of pension 
buy-ins and buyouts seeking to be completed while market conditions hold’. PICA 
was advised in this deal by Willkie Farr & Gallagher, while Phoenix was advised 
by CMS and Eversheds Sutherland.84 
• In September, Rothesay announced it would raise an additional £500m in 
shareholder capital to support its longevity risk transfer business ‒ which in 2019 
alone executed around £10bn in new deals. 
• In November, L&G agreed to provide annuities to Prudential (UK) customers with 
guaranteed rates. As part of the deal, all guaranteed benefits will be honoured by 
Prudential and fulfilled by L&G. Prudential (UK), while remaining a UK-registered 
business, is closing down its UK operations in favour of growing its business in the 
Far East. 
                                                 
82 https://www.legalandgeneralgroup.com/media-centre/press-releases/legal-general-launches-guild-living-
bringing-retirement-communities-to-uk-city-centres/ 
83 https://www.professionalpensions.com/news/3077264/-deploys-blockchain-technology-streamline-
pension-reinsurance 
84 Holly Roach (2019) PICA launches reinsurance counterparty to back UK bulk annuities, Professional Pensions, 
5 August. 
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• In November, PIC converted a £800m longevity swap – originally executed in 2017 
with L&G – for a £750m buy-in for Scottish & Southern Energy (SSE) on the back 
of improved funding for the pension scheme. This is the first example of a transfer 
of obligations between counterparties where the first counterparty (L&G) could 
have offered the buy-in itself. In novating the swap between counterparties, it is 
another important milestone in bringing an early form of liquidity to the longevity 
swaps market. The first conversion of a longevity swap to buy-in took place in 2017 
and the SSE conversion is the fifth one to date. PIC said that a longevity swap 
provides a useful first step towards a buy-in.85 
• In November, Scottish Friendly bought the back book of Canada Life’s 127,000 
life and pensions policies, with assets under management increasing by £2.4bn as 
a result. 
• A modest recovery in annuity sales following the big fall in sales after the ‘Freedom 
and Choice’ reforms of 2015. There were 74,000 (internal and open market) annuity 
purchases in 2018/19.  Annuity rates for 65 year olds were 4%, which although 
low by historical standards, exceeded the 3% that a lower-risk fund offered as a 
sustainable withdrawal rate.86 
 
There are a number of reasons explaining the strength of the UK longevity risk transfer 
market in 2018 and 2019. First, funding levels have improved as a result of a) deficit 
reduction contributions and strong equity returns, which have increased asset values, and 
b) lower liability values due to a combination of higher interest rates and lower mortality 
improvements since 2011; 87  UK funds exhibited the first surplus in aggregate since 
2011.88 Second, there has been an increase in capital and competition from insurers which 
have recruited heavily and so have more staff to model pension scheme mortality, provide 
price quotations and implement transactions. Third, there has been an associated increase 
in reinsurance capacity, which is important since most of the longevity risk assumed by 
insurers is reinsured with global reinsurers. Fourth, there has been increasing 
standardisation of the models used to execute transfers, with three dominant examples: 
intermediated, pass through, and captive. Fifth, insurers have been increasing their 
investment in high yielding illiquid matching assets, such as infrastructure, housing and 
urban regeneration, and equity release, and have passed on the additional yield (including 
illiquidity premium) to schemes in the form of lower prices. Sixth, greater certainty over 
how Solvency II reserving requirements operate has helped to reduce margins for prudence. 
Finally, once a scheme closes to new entrants, its maturity increases rapidly: the proportion 
                                                 
85 Susanna Rust (2019) Energy scheme completes rare longevity swap to buy-in conversion, IPE, 13 
November. 
86 Greg Nielson (2019) Glimmers of an annuity market renaissance, Retirement Planner, 7 November. 
87 This is discussed later. 
88 At the end of November 2018, aggregate pension assets were £1.58trn, while aggregate pension liabilities 
were £1.57trn on a section 179 basis, according to the Pension Protection Fund’s Purple Book. Some 3,008 
schemes had a combined deficit of £137.6bn, while 2,442 schemes had a combined surplus of £151.9bn. 
During the previous 10 years, FTE100 companies had paid £82bn into their DB schemes in order to reduce 
their deficits (which equals one-eighth of the £636bn they paid out in dividends). If companies doubled their 
annual pension contributions to £16.6bn, 30% of schemes could buy-out their pension liabilities in 5 years, 
and 70% in 10 years (Kim Keveh (2019) Half of FTSE100 DB schemes could buyout within 10 years, finds 
Barnett Waddingham, Professional Pensions, 1 July). 
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of the scheme’s liabilities due to pensioners increases and the average age of non-
pensioners also increases. Mature schemes tend to attract more favourable pricing because: 
scheme data for pensioners tends to be more reliable than for other types of member, there 
is less uncertainty over the timing and size of future cash flows, and the risk of the actual 
mortality experience deviating from that which was assumed is lower. All this helps to 
reduce the capital an insurer is required to hold.89 Mercer have estimated that by 2030 
more than £600bn of longevity risk transfers will have taken place in the UK, which 
represents more than one-third of the £1.5trn of UK pension fund assets.90  
 
Outside the UK, some significant longevity swaps took place, including: 
• RGA Life Reinsurance Company of Canada, covering 45,000 Manulife Canadian 
annuitants (February). 
• PartnerRe, covering 25,000 Manulife annuitants (March and May). 
• Canada Life Re, €5.5bn, covering 150,000 in-payment and deferred pensioners 
liabilities of Dutch firm VIVAT (March). 
• Canada Life Re, €12bn, for Dutch insurer Aegon (December). 
 
Another innovation was the completion of a longevity swaption. Securis Investment 
Partners announced in January 2020 that they had completed a capital market derisking 
deal with a ‘large well-known life risk carrier’: ‘we have taken structured longevity risk on 
a specific block of business. The transaction was structured as an indemnity derisking tool, 
i.e., without the use of any longevity indices, as a way to optimize the impact for our 
counterparty even further.. [It involved] a direct risk transfer to a Securis fund with no 
intermediary involved,…and was a first in terms of regulatory approval’.91 
 
We had mentioned earlier the problem of capacity constraints in the insurance and 
reinsurance industries. Our conference series is explicitly about capital markets solutions 
to the problem of transferring longevity risk. When the modern form of the longevity risk 
transfer market started in 2006, investment banks, such as J.P.Morgan, with their links to 
capital market investors, were active in the market along with insurers. However, the 
Global Financial Crisis in 2008 and the 2010 US Dodd-Frank (Restoring American 
Financial Stability) Act which followed led to the majority of investment banks 
withdrawing from the market. A few banks with insurance subsidiaries – such as Goldman 
Sachs, owner of Rothesay Life, and Deutsche Bank, owner of Abbey Life – remained for 
a while before they too sold their life businesses. So for the past few years, the market has 
been dominated by insurers and reinsurers. However, they are beginning to see that the 
current growth rates in the market are not sustainable without new sources of external 
capital. 
 
                                                 
89 Attractive pricing opportunities for buy-in/buy-out, XPS Pensions, Briefing Note No, 2, June 2018. 
90 Mark Cobley (2019) Pension insurance deals to top £600bn by 2030, says Mercer, Financial News, 16 
December. 
91 Email announcement from Luca Tres, 8 January 2020. See also Paul Fulcher and Luca Tres (2019) A 
capital management toolkit for life re/insurers, InsuranceERM, 14 March; 
https://www.insuranceerm.com/analysis/a-capital-management-toolkit-for-life-reinsurers.html 
  27 
One new solution to this problem that has emerged recently is the reinsurance sidecar – 
which is a way to share risks with new investors when the latter are concerned about the 
ceding reinsurer having an informational advantage. Formally, a reinsurance sidecar is a 
financial structure established to allow external investors to take on the risk and benefit 
from the return of specific books of insurance or reinsurance business. It is typically set up 
by existing (re)insurers that are looking to either partner with another source of capital or 
set up an entity to enable them to accept capital from third-party investors (Bugler et al. 
(forthcoming)).  
 
It is established as a special purpose vehicle (SPV), with a maturity of 2-3 years. It is 
capitalized by specialist insurance funds, usually by preference shares, though sometimes 
in the form of debt instruments. It reinsures a defined pre-agreed book of business or 
categories of risk. Liability is limited to assets of the SPV and the vehicle is unrated. The 
benefit to insurers is that sidecars can provide protection against exposure to peak longevity 
risks,92 help with capital management by providing additional capacity without the need 
for permanent capital, and can provide an additional source of income by leveraging 
underwriting expertise. The benefit to investors is that they enjoy targeted non-correlated 
returns relating to specific short-horizon risks and have an agreed procedure for exiting; 
investors can also take advantage of temporary price hikes, but without facing legacy issues 
that could affect an investment in a typical insurer. 
 
There are a number of challenges to the use of sidecars in the longevity risk transfer market. 
There is the tension between the long-term nature of longevity risk and investor preference 
for a short-term investment horizon. There are also regulatory requirements on cedants, 
affecting their ability to generate a return. These include: the posting of prudent collateral, 
the underlying assets in the SPV must generate matching cash flows, the risk transfer must 
be genuine, and the custodian/trustee must be financially strong. There is also a risk to 
cedants of losing capital relief if regulatory requirements are not met or they change. 
 
Three reinsurance sidecars were established at the end of 2017 and the beginning of 2018, 
with investment capital provided by private equity investors and hedge funds, in addition 
to insurers and pension funds. 
 
In December, Athene entered into a reinsurance agreement with Voya Financial, covering 
$19bn of fixed, indexed and variable annuity liabilities. The matching assets will be 
managed by Athene Asset Management. By using an ‘enhanced asset management’ 
strategy and positioning itself for ‘incremental value creation in a more favorable credit 
spread environment’, the company hopes to generate ‘mid-teens returns’. The capital is 
supplied mainly by private equity investors, including Apollo, Athene’s parent company, 
Crestview Partners and Reverence Capital Partners.93  
 
                                                 
92 That is, specific individual cashflows that give rise to the greatest uncertainty in value terms. 
93 Athene & Apollo get long-term capital in $19bn annuity reinsurance deal, by Artemis on December 21, 
2017; http://www.artemis.bm/blog/2017/12/21/athene-apollo-get-long-term-capital-in-19bn-annuity-
reinsurance-deal/ 
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In January, RGA Re and RenaissanceRe, announced a new start-up named Langhorne Re, 
which will target in-force life and annuity business. The new company has secured $780m 
of equity capital from RGA, RenaissanceRe and third-party sidecar investors, including 
pension funds and other life companies.94 
In February, the $400m Leo Re Ltd. 2018-1 collateralized reinsurance sidecar was 
executed between Dutch pension fund manager PGGM and Munich Re as a private ILS 
deal. The agreement allows PGGM, which manages the pension assets of the Dutch 
healthcare workers’ scheme, PFZW, to gain access to a share of Munich Re’s portfolio. 
PGGM will enter into direct ILS trades with counterparties, via quota share arrangements 
with a reinsurer, for a proportion of the counterparties’ underwriting book, thereby sharing 
in the cedents’ risks and underwriting returns.95  
In July, the island of Guernsey announced it would develop a simplified structure for the 
ILS market via an all-in-one legal entity that would combine insurance/reinsurance and 
investment activity in one vehicle – described as a ‘Fund of One’. This would create a more 
transparent vehicle for investors which would promote ‘true convergence’ in ILS. Investors 
would establish both an unregulated investment fund and a reinsurance transformer cell. 
This would remove the need for multiple vehicles and allow a sidecar to have both the risks 
and the assets held in a single vehicle. This would help to reduce the challenges often 
associated with multiple vehicles, such as doing business in various jurisdictions, 
regulation, time zones, account rules, audit, and multiple layers of administration 
expenses.96 
Another example of introducing new third-party capital is an initial public offer (IPO). This 
was the route Swiss Re considered in June 2019 when it proposed listing the shares of 
ReAssure – its UK closed book life consolidator business ‒ on the London Stock Exchange. 
The idea was to provide working capital to put into new transactions and grow the UK life 
insurance book under the SwissRe brand. However, the idea was shelved due to weak 
demand and, in December 2019, ReAssure was sold to Phoenix for £3.2bn. In the process, 
Phoenix – which was valued at the time at £5.3bn – became Europe’s biggest consolidator 
of life and pension businesses and justified the acquisition on the grounds that ‘there are 
too many insurance companies in a market which is consolidating..[and the acquisition 
will] give us the opportunity to capture significant cost and capital synergies’.97 
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In September 2019, the European Life Settlement Association launched the ELSA Master 
Agreement for Tertiary Transactions (MATT). The aim was to develop an industry 
standard purchase and sale agreement to make tertiary transactions more costs and time 
efficient – in a similar manner as the ISDA Master Agreement.98 
At the same time as these practical developments in the capital markets were taking place, 
academics were continuing to make progress on theoretical developments, building on the 
original idea of using longevity bonds to hedge longevity risk in the capital markets (Blake 
and Burrows, 2001). These included: 
• Design and pricing of longevity bonds and other longevity-linked products (e.g., 
Blake et al. (2006a,b, 2014), Bauer (2006), Bauer and Ruβ (2006), Antolin and 
Bloomestein (2007), Bauer and Kramer (2007), Denuit et al. (2007), Barbarin 
(2008), Bauer et al. (2010b), Chen and Cummins (2010), Kogure and Kurachi 
(2010), Bravo (2011), Dowd et al. (2011a), Mayhew and Smith (2011), Zhou et al. 
(2011, 2013), Chen et al. (2013), Shen and Siu (2013), Denuit et al. (2015), Hunt 
and Blake (2015), Milevsky and Salisbury (2015), Yang et al. (2015), Wang and Li 
(2016), Chen et al. (2017), Lin et al. (2017), Leung et al. (2018), MacMinn and 
Richter (2018), Mayhew et al. (forthcoming)). 
• Design and pricing of longevity-linked derivatives (e.g., Shang et al. (2011), Lin et 
al. (2013), Wang and Yang (2013), Chuang and Brockett (2014)) and specifically 
survivor/longevity swaps (e.g., Dowd et al. (2006), Wang et al. (2013, 2015)), 
survivor/longevity forwards and swaptions (e.g., Dawson et al. (2010)), q-forwards 
(e.g., Deng et. al. (2012), Barrieu and Veraart (2016)), mortality options (e.g., 
Milevsky and Promislow (2001), Zhou and Li (forthcoming)), and guaranteed 
annuity options (e.g., Gao et al. (2015)) 
• Pricing longevity risk (e.g., Olivieri and Pitacco (2008), Bayraktar et al. (2009), 
Chen et al. (2010), Li (2010)). 
• The pricing of longevity-related guarantees (e.g., Yang et al.(2008)) 
• The pricing and hedging of life settlements (e.g., Deng et al. (2011), Brockett et al. 
(2013), Zhu and Bauer (2013), MacMinn and Zhu (2017)) 
• Longevity and mortality indices (e.g., Denuit (2009), Li et al. (2011), Chan et al. 
(2014), Tan et al. (2014)) 
• Securitization of longevity risk (e.g., Dahl (2004), Chen and Cox (2009), Cowley 
and Cummins (2005), Lin and Cox (2005), Cairns et al. (2006a), Cox and Lin 
(2007), Biffis and Blake (2010, 2013, 2014), Wills and Sherris (2010), Lane (2011), 
Mazonas et al. (2011), Blake et al. (2013), Yang and Huang (2013), Michaelson 
and Mulholland (2014), Li et al. (2017), MacMinn and Brockett (2017), Bugler et 
al. (forthcoming)) 
• Management and hedging of longevity risk (e.g., Dahl and Møller (2006), Friedberg 
and Webb (2007), Cocco and Gomes (2008), Tsai et al. (2010), Wang et al. (2010), 
Coughlan et al. (2011), Koijen et al. (2011), Li and Hardy (2011), and Tzeng et al. 
(2011), Wang et al. (2010, 2011b), Ngai and Sherris (2011), Barrieu et al. (2012), 
International Monetary Fund (2012), Li and Luo (2012), Cairns (2013), Cox et al. 
(2013a,b), Qiao and Sherris (2013), Cairns et al. (2014), Zelenko (2014), Zhu and 
                                                 
98 https://www.derivsdocu.com/services/consultancy/What-is-an-ISDA-Master-Agreement/ 
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Bauer (2014), Li et al. (2017a), Wong et al. (2017), Zhou and Li (2017), D’Amato 
et al. (2018), Liu and Li (2016, 2018), Hanbali et al. (2019), Kessler (forthcoming), 
Cairns and El Boukfaoui (forthcoming), Hsieh et al. (forthcoming), Li et al. 
(forthcoming), Liu and Li (forthcoming), MacMinn and Zhu (forthcoming)) 
• Mortality modeling, mortality term structure 99  modelling, and mortality 
forecasting (e.g., Heligman and Pollard (1980), Hobcraft et al. (1982), Alho (1990), 
Lee and Carter (1992), Thatcher et al. (1998), Wilmoth and Horiuchi (1999), Booth 
et al. (2002a,b), Brouhns et al. (2002a,b, 2005), Renshaw and Haberman (2003a,b, 
2006, 2008), Currie et al. (2004), Biffis (2005), Bongaarts (2005), Czado et al. 
(2005), Cairns et al. (2006b, 2008a,b, 2009, 2011a), De Jong and Tickle (2006), 
Delwarde et al. (2007), Koissi et al (2006), Pedroza (2006), Bauer et al. (2008), 
Blake et al. (2008), Gourieroux and Monfort (2008), Hari et al. (2008), Kuang, et 
al. (2008), Haberman and Renshaw (2009, 2011, 2012, 2013), Hatzopoulos and 
Haberman (2009, 2011), Li et al. (2009, 2013, 2015a,b, 2017b), Plat (2009a,b), 
Wang and Preston (2009), Bauer et al. (2010a), Biffis and Blake (2010), Biffis et 
al. (2010), Cox et al. (2010), Debonneuil (2010), Dowd et al. (2010a,b), Lin and 
Tzeng (2010), Murphy (2010), Yang et al. (2010), Coelho and Nunes (2011), Currie 
(2011, 2016), D’Amato et al. (2011, 2012a,b), Ediev (2011), Gaille and Sherris 
(2011), Li and Chan (2011), Milidonis et al. (2011), Russo et al. (2011), Russolillo 
et al. (2011), Sweeting (2011), Wang et al. (2011a), Yue and Huang (2011), Zhu 
and Bauer (2011), Alai and Sherris (2014b), Aleksic and Börger (2012), Hainaut 
(2012), O’Hare and Li (2012, 2017), Wilmoth et al. (2012), Hyndman et al. (2013), 
Kleinow and Cairns (2013), Mitchell et al. (2013), Nielsen and Nielsen (2014), 
Hunt and Blake (2014, forthcoming a,b,c,d), Villegas and Haberman (2014), Danesi 
at al. (2015), Tomas and Planchet (2015), Leng and Peng (2016), Schinzinger et al. 
(2016), van Berkum et al. (2016), Beutner et al. (2017), Deprez et al. (2017), 
Kleinow and Richards (2017), Li and Lu (2017), Li and O’Hare (2017), Milidonis 
and Efthymiou (2017), Neves et al. (2017), Shang and Hyndman (2017), Tsai and 
Lin (2017), Börger and Schupp (2018), Debonneuil et al. (2018), Hainaut (2018), 
McCarthy (2018), Salhi, and Thérond (2018), Hilton et al. (2019), Boumezoued 
(forthcoming), Guo and Bauer (forthcoming), McCarthy and Wang (forthcoming), 
Su and Yue (forthcoming), Venter and Şahln (2018), Yue et al. (forthcoming)) 
• Multi-population mortality modelling (e.g., Darkiewicz and Hoedemakers (2004), 
Li and Lee (2005), Cairns et al. (2011b), Dowd et al. (2011b), Jarner and Kryger 
(2011), Njenga and Sherris (2011), Börger and Ruß (2012), Torri and Vaupel 
(2012), D’Amato et al. (2014), Raftery et al. (2014), Zhou et al. (2014), Chen et 
al.(2015), Kleinow (2015), Biffis et al. (2017), Li et al. (2015c, 2017), De Jong et 
al. (2016), Enchev et al. (2017), Zhu et al. (2017), Hunt and Blake (2018), Pascariu 
et al. (2018), Wang et al. (2018), Yang et al. (forthcoming), Chang et al. 
(forthcoming)) 
• Cause-of-death mortality modelling (e.g., Beard (1971), McNown and Rogers 
(1992), Christensen and Vaupel (1996), Hanewald (2011), Murphy and Di Cesare 
(2012), Alai et al. (2014), Arnold and Sherris (2015), Gourieroux and Lu (2015), 
                                                 
99 The mortality term structure is the two-dimensional surface showing projected mortality rates at different 
ages for different future years. 
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Alai et al. (2018), Boumezoued et al. (2018), Yue et al. (2018), Li et al. (2019), Lyu 
et al. (forthcoming)) 
• Longevity risk and financial innovation (improvements in the analysis and design 
of longevity-linked products) (e.g., Gong and Webb (2010), Stevens at al. (2010), 
Richter and Weber (2011), Cocco and Gomes (2012), Brown and Warshawsky 
(2013), Bernhardt and Donnelly (2019)) 
• Reverse or equity release mortgages (e.g., Wang et al. (2008), Huang et al. (2011), 
Yang (2011), Alai et al. (2014a), Kogure et al. (2014), Shao et al. (2015), Lee et al.  
(2018)) 
• Longevity risk in investment portfolios (e.g., Milevsky and Young (2007), 
Menoncin (2008), Horneff et al. (2008, 2009, 2010, 2015), Huang et al. (2012), 
Maurer et al. (2013), Aro and Pennanen (2017), Rogalla (forthcoming)) 
• Longevity risk in pension plans, pension systems and annuities (e.g., Aro (2014), 
Bisetti and Favero (2014), Donnelly (2014), Lin et al. (2014, 2015, 2017), Ai et al. 
(2015), Wan and Bertschi (2015), Ai et al. (2017), Bravo and El Mekkaoui de 
Freitas (2018), Bruszas and Siegelin (2018), Cox et al. (2018), Hsieh et al. (2018), 
Kurtbegu (2018), Mayhew et al. (2018), Cox et al. (forthcoming), Dowd et al. 
(forthcoming) 
• Longevity inequality (e.g., Mayhew and Smith (2014, forthcoming), Debón et al. 
(2017), Sanzenbacher et al. (forthcoming)). 
 
As mentioned before, not all paths to progress are smooth. In recent years, this has been 
particularly true currently in the largest market dealing with micro-longevity risk, namely 
life settlements. 100  The life settlements market has been dogged by systematic 
underestimates of policy holders’ life expectancies by certain medical underwriters, issues 
concerning premium financing, frauds, and ethical issues associated with ‘profiting’ from 
individuals dying and policies maturing. In December 2009, Goldman Sachs announced it 
was closing down its QxX.LS index. This was partly because of the reputational issues 
associated with life settlements, but mainly because of insufficient commercial activity in 
the index. While the ethical issues are no different in substance from those relating to the 
macro-longevity market (see, e.g., Blake and Harrison, 2008), the micro-longevity market 
needs to learn some important lessons from the macro-longevity market. The macro-
longevity market has been very successful at promoting good basic research on the analysis 
of the stochastic mortality forecasting models it uses and putting these models into the 
public domain and has also been much more transparent with the data it uses. This suggests 
a way forward for the life settlements micro-longevity market.  
 
Another setback, this time to the macro-longevity market, occurred in April 2012 when a 
number of investment banks – Credit Suisse, Nomura and UBS – pulled out of the 
longevity risk transfer market as a result of additional capital requirements under Basel III. 
                                                 
100  The market for micro-longevity risk trades assets involving a small number of lives. In the case of life 
settlements, for example, the products involve individual lives and hence are subject to a significant degree 
of idiosyncratic mortality risk. This contrasts with the market for macro-longevity risk which deals with 
pension plans and annuity books and hence involves a large number of lives: here idiosyncratic mortality risk 
is much less important than systematic mortality risk which is essentially the trend risk of getting life 
expectancy projections wrong. 
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Investment banks had already been disadvantaged in this market by the Dodd-Frank Act 
which prevented US banks and their affiliates from entering longevity swaps and synthetic 
trades in life settlements. At around the same time, however, a number of insurers and 
reinsurers entered the market, i.e., PICA, SCOR and Munich Re. The following year 
witnessed the start of a process of consolidation in the insurance industry. In August 2013, 
Lucida was purchased by L&G for £150m; at that time, it had 31,000 pensioners on its 
books and £1.4 billion in pension assets. In February 2014, the buy-out business of 
MetLife, which entered the market in 2007 and acquired the pension assets of 20,000 
pensioners worth £3 billion, was sold to Rothesay Life for an undisclosed sum, bringing 
its total assets to £10 billion.   
 
In December 2013, Goldman Sachs sold the majority of its stake in Rothesay Life to 
Blackstone (28.5%), Government of Singapore Investment Corporation (GIC) (28.5%), 
and MassMutual (7%), due to the new regulatory capital requirements faced by banks and 
insurers.101  
 
In 2016, the UK Office for National Statistics (ONS) reported that longevity improvements 
rates at very high ages have slowed down since 2011. A number of reasons were put 
forward to explain this: short-term reasons, such as lower increases in health service and 
long-term care spending as part of the government’s ‘austerity’ spending cuts following 
the 2008-09 Global Financial Crisis; and longer term reasons, such as the fact that most of 
the improvement in life expectancy in the 1990s and 2000s was due to lower mortality 
from circulatory causes, such as heart disease, and there was no longer scope for further 
improvements.102 In 2018, the UK ONS reported that healthy life expectancy – the average 
number of years lived in ‘very good’ or ‘good’ general health – fell for women and rose 
for men, comparing 2015-17 and 2009-11 data. For men, healthy life expectancy at birth 
increased by five months to 63.1 years, while it fell by three months to 63.6 years for 
women. At birth, UK men and women can expect to live with a disability for 16.5 and 20.9 
years, respectively.103  
 
This prompted a debate in the UK about the reliability of life expectancy projections. 
Mortality improvements in UK males averaged 0.6% p.a. over the preceding four years, 
compared with 3.2% p.a. in the decade before and 1.5-2% between 1995 and 2000. The 
most recent view of the UK actuarial profession is that the reduction in the trend 
improvement is permanent. The Mortality Projections Model of the Institute and Faculty 
of Actuaries’ Continuous Mortality Investigation (CMI) – which covers England & Wales 
– published in March 2019 showed that the average cohort life expectancy of a 65-year old 
man in 2018 was 19.8 years, down by five months (or 2.4%) compared with 2017; the 
                                                 
101 In August 2017, Goldman Sachs sold its remaining stake in Rothesay Life to a consortium comprising 
US buy-out firm Blackstone, Singapore's sovereign wealth fund GIC, and US life insurer MassMutual in a 
deal valuing Rothesay Life at around £2bn; http://www.cityam.com/269996/goldman-sachs-sells-final-stake-
2bn-rothesay-life 
102 Anthony Hilton (2016) Life line, Pensions World, May; Accounting for Pensions: Reflecting the cost of 
pension freedoms and life expectancy, Xafinity Punter Southall, April 2018. See also 
www.bbc.com/news/health-4060825. 
103 Stephanie Baxter (2018) ‘Healthy’ life expectancy falls for women, but improves for men, Professional 
Adviser, 13 December. 
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corresponding figure for a 65-year old woman was 22.4 years, also down by 5 months (or 
2.1%).104 US male life expectancy has also been declining between 2015 and 2016 from 
76.3 to 76.1 years. The main causes were unintentional injuries (due to drug, mainly opioid, 
overdoses), death from Alzheimer’s and suicides. Female life expectancy remained 
constant at 81.1 years. Time will tell if this indeed a permanent change in trend or if the 
trend will again reverse in response to advances in applied biotechnology and in molecular 
and regenerative medicine. The most recent evidence from CMI published in December 
2018 comes from their SAPS (Self-Administered Pension Scheme) data set. This covers 
UK members of DB pension schemes and the data has been collected since 2000. The S3 
series mortality tables for the period 2009-16 showed that life expectancy in this select 
group was still increasing when compared with the S2 series mortality tables for the period 
2004-11.105  
 
These developments are part of an emerging global debate covering a wider set of 
demographic issues than just longevity risk. The debate has centred on population ageing 
and its implications. One aspect of population ageing is declining fertility which soon 
translates into an increase in the average age of the population. One reason for declining 
fertility is the choice made by women in developed countries to have fewer children than 
previous generations. But another is male sperm counts falling so fast across the world that 
the human race could be infertile within 50 years. There has been a 60% decline in the 
sperm count of Western men between 1973 and 2011, with 15% of young Western men 
with a sperm count low enough to impair fertility. A variety of explanations have been put 
forward to explain this: lifestyle factors, such as alcohol, smoking, stress, obesity, 
antidepressants, and high doses of ibuprofen; pesticides and industrial pollutants getting 
into the food chain; sunscreen, containing endocrine-disrupting UV filters; non-stick frying 
pans, containing poly- and perfluoroalkyl substances; tight pants; oestrogen in the water 
supply from the female contraceptive pill; and electromagnetic radiation from wi-fi 
routers.106  
 
Another aspect of population ageing is the differential impact on the rich and poor. A recent 
study by the Longevity Science Panel in the UK found that, while life expectancy had 
increased for all socio-economic groups between 2001 and 2015, it increased most for the 
richest cohort. The difference in life expectancy was 7.2 years in 2001, but this had 
increased to 8.4 years in 2015.107 Another study found that, while socio-economic status 
affects the incidence of multimorbidity (two or more of diabetes, coronary heart disease, 
stroke, chronic obstructive pulmonary disease, depression, arthritis, cancer, dementia, and 
Parkinson’s disease), it did not affect the risk of mortality after the onset of these adverse 
health conditions, implying that primary prevention is key to reducing social inequalities 
in mortality (Dugravot et al (2019)). These findings will have implications for fairness 
between different cohorts of the same generation, for example, when governments raise 
the retirement age for all in response to increasing life expectancy. In response to these 
                                                 
104 Rachel Fixen (2019) UK schemes set for 2.5% fall in liabilities after CMI model revamp, IPE, 8 March. 
105 XPS Pensions (2019), New ‘SAPS3’ mortality tables – a confusing message?, Briefing Note No.3, 
January. 
106 India Sturgis (2018) Prepare for Spermageddon, Daily Telegraph Magazine, 27 January. 
107 Life expectancy gap between rich and poor widens, BBC News, 15 February 2018. 
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inequalities, the government set up the UK Longevity Council to advise it on how best to 
use innovations in technology products and services to improve the lives of the older 
population. With the number of people in the UK over the age 65 to double to more than 
20 million over the next half century, the government has set itself the Ageing Society 
Grand Challenge which aims to ensure that people in the UK enjoy an extra 5 years of 
healthy and independent living by 2035, while narrowing the gap between the experience 
of the richest and poorest.108 Some of these issues do not immediately affect the longevity 
risk transfer market, but they might do in due course, so it is important to flag them now.  
 
There are other global developments that could affect life expectancy, positively or 
negatively.  On the positive side, examples include: (1) Steve Horvath (UCLA) and Ken 
Raj (Public Health England) have demonstrated that rapamycin retards epigenetic ageing 
of human cells – using an epigenetic clock (called the Skin and Blood Clock) which is an 
accurate biomarker for ageing that relies on the mathematical precision of the relationship 
between chemical modifications on DNA called methylation and changes in age;109 (2) 
potential reversal of ageing using a younger person’s blood, flowing successful 
experiments with mice; 110  (3) Randall J. Bateman (Washington University School of 
Medicine in St. Louis) has developed a simple blood test that can detect Alzheimer’s 
disease in its earliest stages by measuring levels of the protein amyloid beta which begin 
to collect in the brain 15 to 20 years before symptoms arise and play a key role in the 
development of Alzheimer’s disease; 111  (4) identification of an inflammatory marker 
called sCD14 which is linked to cognitive decline and dementia, allowing early 
intervention;112 (5) identification of a biomarker for tumour initiating (or cancer stem) 
cells;113 (6) the development of protein-destroying drugs, capable of degrading the MYC 
cancer-fuelling protein or the tau protein responsible for Alzheimer’s;114 the Institute of 
Ageing at Newcastle University and the Mayo Clinic in the US have demonstrated that 
killing senescent cells – which have stopped dividing and hence renewing themselves and 
so have lost their purpose, but can destabilize neighbouring cells and promote low level 
inflammation – can be selectively killed (using a process known as senolytics) and this 
helps to postpone multiple age-related disabilities and disease;115 (7) the development of 
CRISPR technology for editing genomes allows scientists to change DNA sequences and 
modify gene function, so that, for example, genetic defects can be corrected and the spread 
of diseases can be prevented; and (8) using artificial intelligence to correct faults in the 
human nervous system, e.g., robotic arms controlled by brain signals replacing lost human 
arms.116 These developments led Bank of America to conclude that the human lifespan 
could soon pass 100 years, with one of the biggest investment opportunities over the next 
decade being in companies working to delay human death, a market expected to be worth 
                                                 
108 https://www.gov.uk/government/news/experts-to-help-uk-champion-ageing-society-opportunities 
109 http://mypharmacynews.com/health-problems/rapamycin-retards-epigenetic-ageing-of-keratinocytes/ 
110 Undulating changes in human plasma proteome profiles across the lifespan, Nature Medicine, 5 
December 2019. 
111 https://medicine.wustl.edu/news/bateman-receives-potamkin-award-for-alzheimers-research/ 
112 Inflammatory marker linked to dementia, EurakAlert! Science News, 9 December 2019. 
113 Labmedica.com, 28 November 2019. 
114 Protein-slaying drugs could be the next blockbuster therapies, Nature Feature, 20 March 2019. 
115 Danny Buckland (2019) We’re living much longer, but are we healthier?, Raconteur.net, 23 May. 
116 Startups.co.uk Newsletter, 30 June 2019. 
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at least $600 billion by 2025.117 Dr Nir Barzilai, founding director of the Institute for 
Aging Research at the Albert Einstein College of Medicine, New York, argues that ‘Death 
is inevitable but ageing is not’.118 On the negative side, examples include: (1) an increase 
in deaths from heart and circulatory diseases in the UK for the first time in 50 years – as a 
result of an increase in obesity and type 2 diabetes; 119 and (2) the World Economic 
Forum’s Global Risks Report 2019 warns of increasing naturally emerging infectious 
disease pandemics and risks posed by revolutionary new biotechnologies, claiming that 
these pose as big a threat as climate change.120 
 
A number of insurers and reinsurers have used the capital markets to securitize some of the 
mortality risk on their book of business, in the form of what have become known as 
mortality-linked (or mortality catastrophe) bonds – see Table 1. Swiss Re has been the most 
active participant in the market, issuing the first security in 2003, known as Vita I.121 Vita 
I was a $400m principal-at-risk variable rate note, where the investors’ principal was at 
risk in certain extreme mortality risk scenarios in exchange for quarterly coupon payments 
of USD three-month Libor plus a spread of 135 basis points. The bond matured on 1 
January 2007.  
Table 1:  Mortality-linked bonds, 2003-2020 
Issuer Cedent Risks covered  Size  Date 
 
Vita Capital Ltd. Swiss Re Extreme mortality $400m Dec 2003 
Vita Capital II 
Ltd. 
Swiss Re Extreme mortality $362m Apr 2005 
Vita Capital III 
Ltd. 
Swiss Re Extreme mortality $705m Jan 2007 
                                                 
117 https://www.cnbc.com/2019/05/08/techs-next-big-disruption-could-be-delaying-death.html 
118 Amelia Hill (2019) Scientists harness AI to reverse ageing in billion-dollar industry, Guardian, 21 
December; https://www.theguardian.com/science/2019/dec/21/scientists-harness-ai-to-reverse-ageing-in-
billion-dollar-industry 
119 Haroon Siddique (2019) UK heart disease fatalities rise for first time in 50 years, Guardian, 13 May. 
120 https://cirmagazine.com/cir/epidemic-risks-pose-as-big-a-business-threat-as-climate-change.php 
121 Swiss Re obtains USD 400 million of extreme mortality risk coverage its first life securitisation, news 
release, 8 December 2003;  
 https://www.swissre.com/dam/jcr:edf6b706-4c0b-4fc1-85bf-46a338e36208/pr_20031208_en.pdf 
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Issuer Cedent Risks covered  Size  Date 
 
Nathan Ltd. Munich Re Extreme mortality $100m Feb 2008 
Vita Capital IV 
Ltd. 
Swiss Re Extreme mortality $300m Oct 2010 
Vita Capital IV 
Ltd. (Series V 
and VI) 
Swiss Re Extreme mortality $180m Jul 2011 
Vecta I Ltd. Aurigen 
Reinsurance 
Embedded value 
securitization of 
life insurance 
mortality and 
lapse risk 
$111m Dec 2011 
Vita Capital V 
Ltd. 
Swiss Re Extreme mortality $275m Jul 2012 
Mythen Re Ltd. 
(Series 2012-2) 
Swiss Re U.S. hurricane, 
UK extreme 
mortality 
$200m Nov 2012 
Atlas IX Capital 
Limited (Series 
2013-1) 
SCOR Global 
Life SE 
Extreme mortality $180m Sep 2013 
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Issuer Cedent Risks covered  Size  Date 
 
Chesterfield 
Financial 
Holdings LLC 
(Series 2014-1) 
Reinsurance 
Group of 
America 
Embedded value 
securitization of 
life insurance 
mortality and 
lapse risk 
$300m Dec 2014 
Valins I Limited Aurigen 
Reinsurance 
Embedded value 
securitization of 
life insurance 
mortality and 
lapse risk 
$175m Jan 2015 
Benu Capital 
Limited 
AXA Global Life Excess mortality 
(France, Japan, 
U.S.) 
$305m Apr 2015 
Vita Capital VI 
Limited (Series 
2015-1) 
Swiss Re Extreme mortality $100m Dec 2015 
Matterhorn Re 
Ltd. (Series 2020-
2) 
Swiss Re U.S. named 
storm, extreme 
mortality in 
Australia, 
Canada, UK 
$255m Feb 2020 
Source: https://www.artemis.bm/deal-directory/ 
 
As with the previous conferences, Longevity 14 consisted of both academic papers and 
more practical and policy-oriented presentations. There were six plenary sessions: 
Mortality trends and forecasts, How much intergenerational risk sharing is optimal?, Using 
risk analytics and state of the art technology to optimize the value of a pension risk transfer 
business and the practical application of longevity research, Stimulating the longevity 
index market, and Longevity investments and the regulatory dimension. The following 
keynote speakers and panellists contributed to these sessions:  
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• Professor James Vaupel (AXA Professor of Longevity Research and Director of 
the Interdisciplinary Center for Research and Education on Population Change at 
the University of Southern Denmark) gave the opening presentation entitled 
‘Longevity: Past and future’. He argued that extrapolation was a better way of 
predicting life expectancy than actuarial forecasts, highlighting longevity-boosting 
developments such as potential treatments for cancer and ageing, as well as the 
rejuvenation of skin and organs. 
• Peter Banthorpe (Senior Vice President and Head of Global Research and 
Development with RGA Reinsurance Company) discussed ‘Mortality trends and 
forecasts across the UK, US, and Canadian Markets’. 
• Michel Vellekoop and Wilbert Ouburg (Dutch Actuarial Society) gave a 
presentation on ‘Increasing the stability of mortality projections: the Dutch 
approach’. 
• Peter Vlaar (Senior Strategist ALM, APG) discussed ‘The ever lasting Dutch 
pension debate: How much collectivity do we want to keep?’ 
• Professor Michel Vellekoop (Professor in Actuarial Sciences and Mathematical 
Finance, Universiteit van Amsterdam) spoke about ‘Longevity risk sharing in 
collective pension schemes: current practice and proposals for alternatives’. 
• Amy Kessler (Senior Vice President and head of Longevity Risk Transfer, 
Prudential Financial, Inc.) gave a presentation entitled ‘Everybody out of the pool: 
Optimizing outcomes if there is a shift from a collective to an individual pension 
risk system’. 
• Jeff Mulholland (Managing Director, PwC) talked about ‘Using risk analytics to 
optimize the value of a pension risk transfer business’ and discussed practical 
applications of state of the art longevity research. 
• Mark Higgins (Chief Operating Officer, Beacon) presented on ‘Technology 
solutions for optimizing the value of a pension risk transfer business’. 
• Guy Coughlan (Chief Risk Officer, USS) gave a talk on ‘Inequality: Wealth, health 
and longevity’. 
• Sarah Bates (Former Chair of St. James's Place Wealth Management) spoke about 
‘Intergenerational wealth transfers, social inequality and immobility’. 
• Douglas Anderson (Founder, Club Vita) talked about ‘Completing the circle: 
Overcoming the final hurdles to stimulating the longevity index market’. 
• Cord-Roland Rinke (Managing Director, Hannover Re) discussed ‘A new 
framework for longevity index covers’. 
• Avery Michaelson (Founding Partner, Longitude Solutions) considered ‘Increasing 
longevity investment opportunities for capital markets investors’. 
• Leendert van Gastel (Solvency Supervisor, Netherlands National Bank) spoke 
about ‘Longevity risk mitigation from a supervisory perspective’. 
The academic papers that were selected by us as the editors of this Special Issue went 
through a refereeing process subject to the usual high standards of the Annals of Actuarial 
Science. They cover the following themes: longevity hedging, annuities and other pension 
products, demographic inequalities in mortality, mortality data reliability in internal 
models, mortality models, and identifiability in mortality models. We briefly discuss each 
of the 12 papers selected.   
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In ‘Longevity trend risk over limited time horizons’, Stephen J. Richards, Iain D. Currie, 
Torsten Kleinow, and Gavin Ritchie consider various aspects of longevity trend risk 
viewed through the prism of a finite time window. They point out that Solvency II in the 
European Union, and similar regulations elsewhere, specify a value-at-risk (VaR) approach 
to solvency assessment. Other territories specify regulations based around conditional tail 
expectations (CTE), also known as tail-VaR (tVaR). Both solvency approaches view risk 
over a one-year horizon, and both calculations can be performed using the same sample 
data. The authors show the broad equivalence of value-at-risk capital requirements at a p-
value of 99.5% to conditional tail expectations (CTEs) at 99%. They also show how 
deferred annuities have higher risk, which can require double the solvency capital of 
equivalently-aged immediate annuities. However, results vary considerably with the choice 
of model, and so longevity trend-risk capital can only be determined through consideration 
of multiple models to inform actuarial judgement. This model risk is even starker when 
trying to value longevity derivatives. The authors briefly discuss the importance of using 
smoothed models and describe two methods to considerably shorten VaR and CTE run-
times. 
 
Kenneth Q. Zhou and Johnny Siu-Hang Li argue in ‘Asymmetry in Mortality Volatility 
and its Implications on Index-based Longevity Hedging’ that mortality volatility is 
crucially important to many aspects of index-based longevity hedging, including 
instrument pricing, hedge calibration, and hedge performance evaluation. Their paper sets 
out to develop a deeper understanding of mortality volatility and its implications on index-
based longevity hedging. First, they study the potential asymmetry in mortality volatility 
by considering a wide range of GARCH-type models that permit the volatility of mortality 
improvements to respond differently to positive and negative mortality shocks. They then 
investigate how the asymmetry of mortality volatility may impact index-based longevity 
hedging solutions by developing an extended longevity Greeks framework, which 
encompasses longevity Greeks for a wider range of GARCH-type models, an improved 
version of longevity vega, and a new longevity Greek known as `dynamic delta'. The 
theoretical work is complemented by two real-data illustrations, the results of which 
suggest that the effectiveness of an index-based longevity hedge could be significantly 
impaired if the asymmetry in mortality volatility is not taken into account when the hedge 
is calibrated. 
 
In ‘Optimal Portfolio Choice with Tontines under Systematic Longevity Risk’, Irina 
Gemmo, Ralph Rogalla, and Jan-Hendrik Weinert derive optimal portfolio choice patterns 
in retirement (ages 66 to 105) for a constant relative risk aversion (CRRA) utility-
maximizing investor facing risky capital market returns, stochastic mortality risk, and 
income-reducing health shocks. Beyond the usual stocks and bonds, the individual can 
invest his assets in tontines. Tontines are cost-efficient financial contracts providing age-
increasing, but volatile cash flows, generated through the pooling of mortality without 
guarantees, which can help to match increasing financing needs at old ages. The authors 
find that a tontine invested in the risk-free asset dominates stock investments for older 
investors without a bequest motive. However, with a bequest motive, it is optimal to replace 
the tontine investment over time with traditional financial assets. Our results indicate that 
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early in retirement, a tontine is only an attractive investment option, if the tontine funds are 
invested in a risky asset. In this case, they crowd out stocks and risk-free bonds in the 
optimal portfolios of younger investors. Over time, the average optimal portfolio weight of 
tontines decreases. Introducing systematic mortality risks noticeably reduces the peak 
allocation to tontines. 
 
In ‘Linking Annuity Benefits to the Longevity Experience: Alternative Solutions’, 
Annamaria Olivieri and Ermanno Pitacco argue that uncertainty about financial returns and 
life expectancy, combined with reduced social security benefits, increasingly expose 
individuals to the risk of outliving their post-retirement assets. However, the demand for 
longevity guarantees remains low, due to high costs. The providers, on their side, may be 
reluctant to offer nonadjustable longevity guarantees, as the risk is long-term and difficult 
to predict. It is therefore convenient to reconsider the design of longevity guarantees. In 
particular, a participating structure, providing a link to some longevity experience, could 
allow a sharing of losses, and possibly profits, resulting in a reduction of the cost of the 
retained guarantee. The literature has proposed a number of alternatives to define a 
longevity linking arrangement, but the topic is not yet completely explored. It is useful, in 
particular, to have a common framework, under which the various solutions can be 
interpreted and compared, also with a view to the trade-off between the retained risk and 
the cost of the guarantee. The main purpose of the paper is to develop a general structure 
describing longevity-linked post-retirement benefits is. Allowing for aggregate longevity 
risk, the authors then examine suitable solutions for insurance products. 
 
Anne G. Balter, Malene Kallestrup-Lamb, and Jesper Rangvid point out in ‘Variability in 
Pension Products: A Comparison Study between the Netherlands and Denmark’ that the 
Danish and Dutch pension systems are, according to the Melbourne Mercer Global Pension 
Index ‘among the best in the world’ in terms of adequacy (the size of pension savings), 
integrity (the governance of the pension providers), and the overall sustainability 
(coverage, assets, contributions and demography) of the pension system.122 In spite of 
large pension savings, both systems face challenges. Key ones are the current low-interest 
rate environment coupled with increasing life expectancy which makes it increasingly 
difficult for pension providers to honour promised (and certainly guaranteed) pensions. As 
a consequence, both sectors have undergone and are undergoing considerable change. The 
authors compare the two countries’ pension systems and pension products. They focus on 
the shifts that have taken place, from pension products with relatively low levels of risk for 
the participant, to pension products with more risk but also higher expected return. They 
end by drawing lessons that are relevant for discussions in many countries. 
 
In ‘An Investigation into the Impact of Deprivation on Demographic Inequalities in 
Adults’, Les Mayhew, Gillian Harper, and Andrés M. Villegas investigate the impact of 
deprivation on demographic inequalities in England and Wales among adults. Using 
demographic measures, including the modal age at death, life expectancy, lifespan 
variation and mortality, the authors show a negative correlation with deprivation as 
measured by the 2015 Index of Multiple Deprivation. Although the study finds that life 
expectancy is increasing overall and the gap between men and women is narrowing, 
                                                 
122 https://info.mercer.com/rs/521-DEV-513/images/MMGPI%202019%20Full%20Report.pdf 
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improvements are slower paced in more deprived areas and the gap between rich and poor 
is slowly worsening over time. Men are more adversely impacted by deprivation than 
women with the gap in period life expectancy at age 30 in 2015 between the top and bottom 
1% of deprived neighbourhoods at 10.9 years for men and 8.4 years for women. Between 
2001 and 2015, inequalities in male mortality rates at age 44 were 4.4 times greater in the 
most deprived 10% of neighbourhoods than those in the 10% least deprived, and were 
much higher than in intervening deciles. The worst deprivation is concentrated in specific 
areas. For example, in 22 out of 326 English districts, 25% or more of neighbourhoods are 
in the most deprived 10% and in 5 districts it is 40% or above. 
 
The paper on ‘Mortality in the US by Education Level’ by Cristian Redondo Lourés and 
Andrew J.G. Cairns, recognizing the differences in mortality rates by socioeconomic 
group, uses a variety of data sources, including highly-detailed cause-of-death data from 
the United States Centers for Disease Control and Prevention, to explore the mortality gap 
between the better and worse off in the US during the period 1989-2015, using education 
as a proxy. 
 
In ‘Mortality data reliability in an internal model’, Fabrice Balland, Alexandre 
Boumezoued, Laurent Devineau, Marine Habart, and Tom Popa discuss the impact of some 
mortality data anomalies on an internal model capturing longevity risk in the Solvency II 
framework. In particular, the authors are concerned with abnormal cohort effects such as 
those for the generations born in 1919 and 1920, for which the period tables provided by 
the Human Mortality Database show particularly low and high mortality rates, respectively. 
To provide corrected tables for three countries of interest (France, Italy and West 
Germany), the authors use the approach developed by Boumezoued (forthcoming) for two 
countries with reliable monthly fertility data (France and Italy) and provide an extension 
of the approach for West Germany where monthly fertility data are not sufficient to cover 
the generations of interest. These mortality tables are crucial inputs to stochastic mortality 
models forecasting future scenarios, from which the extreme 0.5% longevity improvement 
can be extracted, allowing for the calculation of the Solvency Capital Requirement (SCR). 
More precisely, to assess the impact of such anomalies in the Solvency II framework, the 
authors use a simplified internal model based on three common stochastic models to project 
mortality rates in the future combined with a closure table methodology for older ages. 
Correcting this bias obviously improves the data quality of the mortality inputs, which is 
of paramount importance today, and slightly decreases the capital requirement. Overall, 
the longevity risk assessment remains stable, as well as the selection of the stochastic 
mortality model. As a collateral gain of this data quality improvement, the more regular 
estimated parameters allow for new insights and a refined assessment regarding longevity 
risk. 
 
The aim of ‘CBDX: A Workhorse Mortality Model from the Cairns-Blake-Dowd Family’, 
by Kevin Dowd, Andrew J.G. Cairns and David Blake, is to identify a workhorse mortality 
model for the adult age range (i.e., excluding the accident hump and younger ages). It 
applies the ‘general procedure’ (GP) of Hunt and Blake (2014) to identify an age-period 
model that fits the data well before adding in a cohort effect that captures the residual year-
of-birth effects arising in the original age-period model. The resulting model is intended to 
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be suitable for a variety of populations, but economises on the number of period effects in 
comparison with a full implementation of the GP. The authors estimate the model using 
two different iterative Maximum Likelihood (ML) approaches – one Partial ML and the 
other Full ML – that avoid the need to specify identifiability constraints.  
 
In ‘Identifiability in Age/Period Mortality Models’, Andrew Hunt and David Blake argue 
that as the field of modelling mortality has grown in recent years, the number and 
importance of identifiability issues within mortality models has grown in parallel. This has 
led both to robustness problems and to difficulties in making projections of future mortality 
rates. In this paper, the authors present a comprehensive analysis of the identifiability issues 
in age/period mortality models in order to first understand them better and then to resolve 
them. To achieve this, they discuss how these identifiability issues arise, how to choose 
identification schemes which aid our demographic interpretation of the models and how to 
project the models so that our forecasts of the future do not depend upon the arbitrary 
choices used to identify the historical parameters estimated from historical data. 
 
In a companion paper, ‘Identifiability in Age/Period /Cohort Mortality Models’, Andrew 
Hunt and David Blake show that the addition of a set of cohort parameters to a mortality 
model can generate complex identifiability issues due to the collinearity between the 
dimensions of age, period and cohort. These issues can lead to robustness problems and 
difficulties making projections of future mortality rates. Since many modern mortality 
models incorporate cohort parameters, the authors believe that a comprehensive analysis 
of the identifiability issues in age/period/cohort mortality models is needed. In this paper, 
they discuss the origin of identifiability issues in general models before applying these 
insights to simple but commonly used mortality models. They then discuss how to project 
mortality models. 
 
Finally, in ‘Constraints, the Identifiability Problem and the Forecasting of Mortality’, Iain 
D. Currie points out that models of mortality often require constraints in order that 
parameters may be estimated uniquely. He argues that it is not difficult to find references 
in the literature to the ‘identifiability problem’ and papers often give arguments to justify 
the choice of particular constraint systems designed to deal with this problem. Many of 
these models are generalized linear models and it is known that the fitted values (of 
mortality) in such models are identifiable, i.e., invariant with respect to the choice of 
constraint systems. The author shows that for a wide class of forecasting models, namely 
ARIMA(p; δ; q) models with a fitted mean and δ = 1 or 2, identifiability extends to the 
forecast values of mortality; this extended identifiability continues to hold when some 
model terms are smoothed. The results are illustrated with data on UK males from the 
Office for National Statistics for the age-period model, the age-period-cohort model, the 
age-period-cohort-improvements model of the Continuous Mortality Investigation and the 
Lee-Carter model. 
 
 
Longevity 15 took place in Washington DC on September 12-13, 2019. Insurance: 
Mathematics and Economics will publish a Special Issue of selected papers presented at 
this conference. Longevity 16 will take place in Singapore on September 9-10, 2021. The 
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Journal of Demographic Economics will publish a Special Issue of selected papers 
presented at this conference. Longevity 17 will take place in Copenhagen in 2022 and 
Longevity 18 will take place in Toronto in 2023.  
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